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Abstract 
Chapter 1: The design of a novel first aid smart fabric that is linked to a biologically 
active molecule through an event specific cleavable linker is described. Successful 
functionalization of a cellulose filter paper fabric mimic and the synthesis of a linker 
which is potentially selectively cleavable in the presence of blood have been achieved.    
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Chapter 2: Synthetic studies towards the total synthesis of Torilin, a sesquiterpene 
guaiane natural product with interesting biological activities are described. The synthesis 
of the hydroazulene core of Torilin is accomplished through a cyclopropanation/ Lewis 
acid mediated fragmentation of a highly functionalized polycyclic system which is 
rapidly accessed through the intramolecular cycloaddition of cyclobutadiene.  
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 Chapter 1: Design and Synthesis of a First Aid Smart Fabric 
 
1.1 Introduction 
In the event of severe bodily injury resulting from an unforeseen accident or 
trauma, the immediate administration of first aid is critical. Often, the first priority of a 
medic on scene is achieving haemostasis. Reducing pain and helping to prevent or 
combat infection at the wound site are also essential. We envisioned that we could design 
a first aid smart fabric that could be used by first responders, doctors, nurses, or even the 
injured party themselves in order to achieve these goals at the time of injury. The first aid 
fabric will contain a biologically active molecule covalently bound to the fabric through 
an event-specific cleavable linker. When blood, caused by an injury, comes into contact 
with the fabric it will release the pharmaceutical into and around the wound site in an 
efficient manner. This first aid fabric could also find utility in police and military 
applications, or it could be incorporated into more everyday items like sports fabrics, 
baby diapers, or automobile airbags and upholstery. 
 
1.2 Background 
 Limited research exists in the area of first aid fabrics.1  The majority of these 
fabrics contain antibacterial or antimicrobial agents which are permanently bound, or 
simply embedded into the polymeric matrix. Since controlling hemorrhaging on the scene 
of a severe trauma still remains the biggest challenge for first responders, the 
development of pre-hospital haemostatic dressings has become an active area of research. 
                                                
1 For a detailed review of first aid fabrics see: Monoalkylation of 1,2-Diols and Design and Synthesis of 
   First Aid Smart Fabrics, Angell, V. L. Masters Thesis, Department of Chemistry, Boston College, 2012. 
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Those haemostatic agents for which at least some efficacy has been shown will be 
reviewed below.     
 
1.2.1 Pre-hospital Haemostatic Dressings 
 Trauma related hemorrhaging is the leading cause of preventable death in military 
casualties, 2 and the second leading cause of death in civilian casualties.3 In combat 
scenarios, 90% of injuries are caused by projectiles, shrapnel, or improvised explosives. 
These often result in large irregularly shaped wounds, making hemorrhage control with 
traditional methods, such as standard gauze or pressure dressings, difficult. Injuries to 
junction zones such as the axilla, neck, and perineum or wounds to the torso are often 
hard to manage because tourniquet application and effective compression is not possible.4  
Furthermore, in instances such as combat settings, civilian mass casualties, or secluded 
environments, evacuation of the wounded may be seriously delayed. Due to the 
aforementioned reasons, the development of improved pre-hospital haemostatic agents 
has become a priority.  
 Pusateri and coworkers, suggest that haemostatic agents used in pre-hospital 
conditions should meet several ideal criteria.5 First, the haemostatic agent must be able to 
stop large arterial and venous bleeds within two minutes of application, even when 
applied through a pool of blood. Second, the agent must be lightweight, durable and long 
                                                
2 a) Bellamy R. F. Mil. Med. 1984, 149, 59. b) Champion H. R.; Bellamy, R. F.; Roberts, C.P.; Leppaniemi, 
   A. J. Trauma. 2003, 54, S13.  
3 a) Hoyt D.B.; Bulger, E.; Knudsin, M. M.; et al. J. Trauma. 1994, 37, 426. b) Sauaia A.; Moore, F. A.; 
   Moore, E. E.; Moser, K. S.; Brennan, R.; Read, R. A.; Pons, P. T.  J. Trauma. 1995, 38, 185. c) Dorlac, 
   W. C.; DeBakey, M. E.; Holcomb, J. B.; Fagan, S. P.; Kwong, K. L.; Dorlac, G. R.; Schreiber, M. A.;  
   Persse, D. E.; Moore, F. A.; Mattox, K. L.  J. Trauma. 2005, 59, 217. 
4 Champion, H. R.; Bellamy, R.F.; Roberts, C.P.; Leppaniemi, A. J. Trauma. 2003, 54, S13.  
5 Pusateri, A. E.; Holcomb, J. B.; Kheirabadi, B. S.; Alam, H. B.; Wade, C. E.; Ryan, K. L. J. Trauma. 
   2006, 60, 674.  
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lasting even in extreme environments. Third the haemostatic agent must be ready to use, 
with no requirement for mixing of ingredients or other pre-application preparation. 
Finally, the haemostatic device must be inexpensive, safe to use without risk of injury to 
tissues or transmission of infection, and easy to apply by the victim, an onlooker, or 
medic.  
 The haemostatic agents that have been developed thus far can be grouped into 
three categories based on their mechanism of action. Factor concentrators are haemostatic 
devices that work through rapid absorption of the water present in blood. This causes the 
cellular and protein components of the blood to be concentrated which aids in clot 
formation. Mucoadhesive agents help to seal bleeding wounds by physically adhering to 
tissues. The third class of haemostatic agents, procoagulant supplementors, supply the 
wound with factors to promote coagulation. However, many of the haemostatic agents 
that will be discussed possess secondary modes of action that may or may not fall into 
one of these categories.    
 
1.2.1.1 Factor Concentrators  
 QuikClot, an FDA approved granular preparation of Zeolite, is the current 
standard in haemostatic devices, and has been deployed by both the United States (US) 
and British military. Zeolite is an inert mineral composed of oxides of silicon, aluminum, 
sodium, magnesium, and small amounts of quartz. It promotes blood clotting by 
absorbing water, thus concentrating the platelets and clotting factors in blood.6 It is also 
likely that the negatively charged surface of the zeolite helps to activate the intrinsic 
                                                
6 Alam, H. B.; Burris, D.; DaCorta, J. A.; Rhee, P. Mil. Med. 2004, 70, 63.   
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coagulation cascade.7 While relatively inexpensive (approximately $20/dressing), easy to 
apply, and stable for long periods of time, QuikClot has several major disadvantages. It 
absorbs water in a highly exothermic reaction (recorded wound temperatures ranged from 
42-140 °C) which can cause severe tissue damage or even necrosis.8 Furthermore, it is 
not bioabsorbable and thus requires removal before surgical closure, which can be 
difficult due to its granular composition.  
Typically, the efficacy of haemostatic devices is first tested in animal studies 
using three types of bleeding models: venous bleeding, arterial bleeding, and mixed 
arterial and venous bleeding. The ability of the haemostatic agent to achieve haemostasis 
is compared to a standard gauze dressing. Animal studies of QuikClot8b,9 have shown that 
it is effective in controlling venous hemorrhaging and mixed arterial-venous 
hemorrhaging, but is not effective in controlling arterial hemorrhaging.      
 Rhee and coworkers reported the largest case study of QuikClot.8d A total of 103 
uses of QuikClot, including 69 uses in military operations, 14 uses by civilian emergency 
medical responders, and 20 uses by civilian trauma surgeons, were reviewed. The 
                                                
7 a) Arnaud, F.; Tomori, T.; Saito, R.; McKeague, A.; Prusaczyk, W. K.; McCarron, R. M. J. Trauma. 2007, 
63, 775. b) Arnaud, F.; Tomori, T.; Carr, W.;McKeague, A.; Teranishi, K.; Prusaczyk, K.; McCarron, R.  
Ann. Biomed. Eng. 2008, 36, 1708.  
8 a) Wright, J. K.; Kalns, J.; Wolf, E. A.; Traweek, F.; Schwarz, S.; Loeffler, C. K.; Snyder, W.; Yantis, L. 
D.; Eggers, J. J. Trauma. 2004, 57, 224. b) Ahuja, N.; Ostomel, T. A.; Rhee, P.; Stucky, G. D.; Conran, 
R.; Chen, Z.; Al-Mubarak, G. A.; Velmahos. G.; Demoya, M.; Alam, H. B. J. Trauma. 2006, 61, 1312. c) 
McManus, J.; Hurtado, T.; Pusateri, A.; Knoop, K. J. Prehospital Energency Care. 2007, 11, 67. d) Rhee, 
P.; Brown, C.; Martin, M.; Salim, A.; Plurad, D.; Green, D.; Chambers, L.; Demetriades, D.; Velmahos, 
G.; Alam, H. J. Trauma. 2008, 64, 1093.   
9 a) Alam, H. B.; Chen, Z.; Jaskille, A.; Querol, R. I.; Koustova, E.; Inocencio, R.; Conran, R.; Seufert, A.; 
    Ariaban, N.; Toruno, K.; Rhee, P. J. Trauma. 2004, 56, 974. b) Pusateri A. E.; Delgado, A. V.; Dick, E. 
    J.; Martinez, R. S.; Holcomb, J. B.; Ryan, K. L. J. Trauma. 2004, 57, 555. c) Kheirabadi, B. S.; Acheson 
    E. M.; Deguzman, R.; Sondeen, J. L.; Ryan, K. L.; Delgado, A.; Dick, E. J.; Holcomb, J. B. J. Trauma. 
    2005, 59, 25. d) Kozen, B. G.; Kircher, S. J.; Henao, J.; Godinez, F. S.; Johnson, A. S. Acad. Emerg. 
   Med. 2008, 15, 74. e) Eryilmaz, M.; Ozer, T.; Mentes, O.; Torer, N.; Durusu, M.; Gunal, A.; Uzar, A. L. 
   Ulus Travma Acil Cerrahi Derg. 2009, 15, 7. f) Li, J.; Yan, W.; Jing, L.; Xueyong, L.; Yuejun, L.; 
   Wangzhou, L.; Shaozong, C. J. Trauma. 2009, 66, 612. g) Arnaud, F.; Parreno-Sadalan, D.; Tomori, T.; 
   et al. J. Trauma. 2009, 67, 848. 
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application site varied and included external application to the head, neck, chest, back, 
buttock, abdomen, pelvis, and limbs; and internal application to the chest, abdomen and 
pelvis during surgery. The overall efficacy rate was reported to be 92%. Out of the 20 
applications in surgery, eight failed in controlling hemorrhaging; however, this was likely 
due to inability to apply the dressing to the direct source of bleeding.  All applications of 
QuikClot by first responders resulted in haemostasis. Some complications, including 
burns and scar formation, due to the severe exothermic reaction upon application were 
reported. 
QuickClot ACS, a modified QuikClot product, has several improvements. A new 
beaded form of zeolite, which is enclosed in a loose mesh bag, allows for more effective 
application and easier removal.8b The second generation QuikClot ACS, QuikClot ACS+ 
is also safer because it only produces a minimally exothermic reaction when it is applied 
to the wound; although studies still showed some tissue damage.8b,10   
 
1.2.1.2 Mucoadhesive Agents  
 HemCon dressings, sterile foam pads impregnated with chitosan acetate salt 
(Figure 1.1), have been used in military operations since 2003,11 and are also considered 
to be the current standard for topical haemostatic dressings. Chitosan is derived from 
chitin, a polymer of N-acetyl glucosamine (Figure 1.1) which is found in the shells of 
marine arthropods. The deacylated product of chitin, where greater than 75% of the 
polymer has been deacylated, is referred to as chitosan. When the chitosan acetate salt 
                                                
10 Kheirabadi, B. S.; Edens, J. W.; Terrazas, I. B.; Estep, J. S.; Klemcke, H. G.; Dubick, M. A.; Holcomb, J.  
    B. J. Trauma. 2009, 66, 316. 
11 a) Wedmore, I.; McManus, J. G.; Pusateri, A. E.; Holcomb, J. B. J. Trauma. 2006, 60, 655. b) Cordts, P. 
    R.; Brosch, L.A.; Holcomb, J. B. J. Trauma. 2008, 64, S14. 
5
  
comes into contact with red blood cells, which are anionic, it produces a rapid cross-
linking causing the chitosan to adhere to the tissue surface which creates a physical 
seal.12  
 
Figure 1.1. The Chemical Structure of Chitin and Chitosan 
 
  
Preclinical trials in animal bleeding models showed that HemCon is effective in 
achieving haemostasis of venous bleeds13 and has some efficacy in mixed arterial-venous 
bleeds.10d,g There is, however, contradictory evidence of HemCon efficacy on arterial 
haemorrhaging.10c,11, 14  Additionally, some mouse studies have shown that HemCon 
possesses antimicrobial properties which may aid in wound healing.15  
                                                
12 a) Rao, S. B.; Sharma C.P. J. Biomed. Mater. Res. 1997, 34, 21. b) Thatte, H. S.; Zagarins, S. E.; Amiji, 
    M.; Khuri, S. F. J. Trauma. 2004, 57, S7.  
13 a) Pusateri, A. E.; Modrow, H. E.; Harris, R. A.; et al. J. Trauma. 2003, 55, 518. b) Bochicchio, G.; 
    Kilbourne, M. Kuehn, R.; Keledjian, K.; Hess, J.; Scalea, T. Am. J. Surg. 2009, 198, 617.   
14 a) Acheson, E. M.; Kheirabadi, B. S.; Deguzman, R.; Dick, E. J.; Holcomb, J. B. J. Trauma. 2005, 59, 
    865. b) Gustafson, S. B.; Fulkerson, P.; Bildfell, R.; Aguilera, L.; Hazzard, T. M. Prehosp. Emerg. Care. 
    2007, 11, 172. c) Kheirabadi, B. S.; Scherer, M. R.; Estep, J. S.; Dubick, M. A.; Holcomb, J. B. J. 
    Trauma. 2009, 67, 450. d) Sohn, V. Y.; Eckert, M. J.; Martin, M. J.; Arthurs, Z. M.; Perry, J. R.; Beekley,  
    A.; Rubel, E. J.; Adams, R. P.; Bickett, G. L.; Rush, R. M. J. Surg. Res.2009, 154, 258.   
15 a) Burkatovskaya, M.; Tegos, G. P.; Swietlik, E.; Demidova, T. N.; Castano, A.; Hamblin, M. R. 
    Biomaterials. 2006, 27, 4157. b) Burkatovskaya, M.; Castano, A. P.; Demidova-Rice, T. N.; Tegos, G.  
    P.; Hamblin, M. R. Wound Repair Regen. 2008, 16, 425. c) Dai, T.; Tegos, G. P.; Burkatovskaya, M.; 
    Castano, A. P.; Hamblin, M. R. Antimicrob. Agents Chemother.  2009, 53, 393.  
6
  
 A 2006 case study12a of HemCon efficacy in combat operations showed that the 
mucoadgesive agent was successful in 97% of uses where standard dressings had failed. 
Application of the HemCon dressing resulted in haemostasis or greatly retarded bleeding. 
The two failures reported in this study arose from blind insertion of dressings into deep 
cavity wounds.  A serious issue with these dressings was that their lack of flexibility 
forced medical staff to have to tear or cut them in order to be able to insert the dressing 
into small or irregularly shaped wounds. In a study of civilian applications16, Brown 
reported a 74% success rate, with haemostasis achieved within three minutes of HemCon 
application after standard gauze application had failed. According to Brown, six out of 
the seven failed cases resulted from incorrect use of the dressing. 
  The HemCon product is now available in several thinner and more flexible forms, 
including bandages and gauze which allows for easier application to irregular wound 
surfaces, and the ability to stuff the dressing into deep wounds or body cavities. HemCon 
products are somewhat expensive (approximately $100/dressing), but are FDA approved, 
biodegradable, nontoxic and easy to apply; however, removal of the dressing is still 
required.6 
 Another FDA approved mucoadhesive agent composed of chitosan is Celox. Like 
HemCon, it is positively charged, and thus acts through a similar mechanism of action, 
forming a sticky barrier around severed vessels. It is granular in nature and must be 
poured into the wound, making it difficult to apply. However, since its original 
development, improvements have been made to its design, and new versions of the 
product include a transparent bag which dissolves upon contact with blood. Additionally, 
                                                
16 Brown, M. A.; Daya, M. R.; Worley, J. A. J. Emerg. Med. 2009, 37, 1.  
7
  
a gauze preparation is also available. Celox is also relatively inexpensive (approximately 
$26 dollars/packet).6 However, although it is bioabsorbable, it must be removed from the 
wound prior to surgical closure.    
 Studies of Celox powder in animal bleeding models have shown its efficacy in 
controlling mixed arterial-venous hemorrhages10d,g and arterial hemorrhages.11,15c,17 In 
both the mixed and arterial hemorrhage studies, Celox was shown to outperform both 
HemCon and QuikClot ACS+. Efficacy of the Celox bags and gauze has not been proven 
in animal bleeding models. Furthermore, no data of Celox effectiveness in humans exists. 
WoundStat (approximately $30/packet)6 is yet another FDA approved 
mucoadhesive haemostatic agent. It is composed of a smectite mineral containing sodium, 
calcium and aluminum silicate; and a water absorbent poly-acrylic acid salt.18 Upon 
contact with blood, WoundStat acts by several different mechanisms including both 
swelling of the dry smectite granules into a clay-like substance which seals the wound, 
and the concentration of clotting factors through water absorption. The smectite granules 
also carry a negative charge which may play a role in activating the intrinsic coagulation 
pathway.11,19 The non-biodegradable granules must be poured into the wound, and are 
thus very difficult to fully remove, even with several washouts.20 
 In studies11,19 comparing WoundStat to Celox powder, HemCon and QuikClot 
ACS+, WoundStat was found to be superior to the other three in establishing haemostasis 
in both arterial bleeds and mixed arterial-venous bleeds. In fact, all research to date has 
                                                
17 Kozen, B.; Kircher, S.; Henao, J.; Godinez, F.; Johnson, A. Ann. Emerg. Med. 2007, 50, S60. 
18 Ward, K. R.; Tiba, M. H.; Holbert, W. H.; Blocher, C. R.; Draucker, G. T.; Proffitt, E. K.; Bowlin, G. L.; 
    Ivatury, R. R.; Diegelmann, R. F. J. Trauma. 2007, 63, 276. 
19 Odom, I. E. R. Soc. Lond. Philos. Trans. Ser. A Math. Phys. Eng. Sci. 1984, 311, 391. 
20 Kheirabadi, B. S.; Estep, S. J. US Army Institute of Surgical Research. 2008, 4. 
8
  
shown WoundStat to be 100% effective in achieving haemostasis. No studies of 
WoundStat efficacy in venous hemorrhaging models have been reported.  
Unfortunately, a subsequent evaluation of WoundStat by Kheirabadi and 
coworkers21 revealed some serious safety concerns. Woundstat was applied to carotid 
vessels of swine, followed by subsequent removal of the WoundStat granules and suture 
repair. It was found that seven out of the eight arteries and six of the eight veins treated 
had no flow and were suffering from occlusive thrombi. Residue from the granules and 
small clots were also found in the lungs of two of the animals.  Due to the clear 
endothelial damage, and the threat for distal thrombi, it was concluded that WoundStat 
was not safe for use.   
 
1.2.1.3 Procoagulant Supplementors 
 Dry Fibrin Sealant Dressing (DFSD), a product of the US Military and the 
American Red Cross, consists of a polyglactin backing impregnated with highly purified 
powdered human fibrinogen, thrombin, calcium, and coagulation factor XIII. DFSD helps 
achieve haemostasis by providing a high concentration of clotting factors at the wound 
site.6 Efficacy of this haemostatic agent has been demonstrated in venous22 and arterial 
hemorrhage models.15a,23 One study15a, comparing several haemostatic agents, found 
                                                
21 Kheirabadi, B. S.; Mace, J. E.; Terrazas, I. B.; Fedyk, C. G.; Estep, J. S.; Dubick, M. A.; Blackbourne, L. 
    H. J. Trauma. 2010, 68, 269. 
22 a) Holcomb, J. B.; Pusateri, A. E.; Harris, R. A.; Charles, N. C.; Gomez, R. R.; Cole, J. P.; Beall, L. D.; 
    Bayer, V.; MacPhee, M. J.; Hess, J. R. J. Trauma. 1999, 46, 49. b) ) Holcomb, J. B.; Pusateri, A. E.; 
    Harris, R. A.; Reid, T. J.; Beall, L. D.; Hess, J. R.; MacPhee, M. J. J. Trauma. 1999, 47, 233. 
    c) Jewelewicz, D. D.; Cohn, S. M.; Crookes, B. A.; Proctor, K. G. J. Trauma. 2003, 55, 621. 
23 a) Larson, M. J.; Bowersox, J. C.; Lim, R. C.; Hess, J. R. Arch. Surg. 1995, 130, 420. b) Sondeen, J. L.; 
    Pusateri, A. E.; Coppes, V. G.; Gaddy, C. E.; Holcomb, J. B. J. Trauma. 2003, 54, 280. c) Kheirabadi, B. 
    S.; Acheson, E. M.; Deguzman, R.; Crissey, J. M.; Delgado, A. V.; Estep, S. J.; Holcomb, J. B. J.  
   Trauma. 2007, 62, 94.  
9
  
DFSD to be superior to QuikClot and HemCon. Despite being briefly operationally 
deployed15c, this dressing has not yet achieved FDA approval. Furthermore, its flakey 
consistency, thick inflexible backing, and its cost of nearly 500 times that of QuikClot 
(approximately $1,000), makes it difficult to consider DFSD for widespread pre-hospital 
use.6   
 In 2008, a new FDA approved product called Combat-Gauze made its way onto 
the market. This haemostatic device, costing approximately $30,6 consists of a gauze roll 
that is impregnated with Kaolin. Kaolin is an aluminum silicate mineral that is known to 
activate the intrinsic coagulation pathway.11 The gauze is flexible and easy to apply, but 
is not biodegradable and must be removed before surgical repair. Efficacy in an arterial 
bleeding model has been demonstrated.15c In this study, which included HemCon and 
other less known haemostatic agents, CombatGauze was the most effective agent, with an 
80% survival rate. The safety of CombatGauze was also assessed by Kheirabadi in the 
same study that examined WoundStat safety.21 No damage or distal clots were found 
from use of CombatGauze. CombatGauze has been deployed in military operations, but 
no data on its efficacy in trauma use has been reported.  
 
1.2.2 Background Summary 
 While it is clear that impressive strides have been made in the area of pre-hospital 
haemostatic agents, there is still no single haeomostatic device that meets all of the 
criteria established by Pusateri. The dressings described above are plagued by issues such 
as exothermicity, endothelial damage, undesired side effects, cost, difficulties in 
application and/or removal, or simple inefficacy in complicated hemorrhage situations. 
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Furthermore, data on shelf life stability and case studies of actual use in trauma are 
missing for some of these devices.    
The development of an improved haemostatic agent is still needed, the criteria 
established by Pusateri are yet to be met by existing hemostatic devices. However, the 
exclusion of certain features found in the dressings described above and the inclusion of 
new features, may aid in the synthesis of an ‘ideal’ haemostatic agent. We believe that 
the unique design of our first aid smart fabric may begin to meet some of these goals.  
 
1.3 First Aid Smart Fabric Design 
The design for our first aid smart fabric (Figure 1.2) consists of four components: 
the solid support, which is the fabric itself, a spacer arm whose purpose is to provide 
distance between the solid support of the fabric and the site of reactivity, an event-
specific cleavable linker, and a pharmaceutical agent of choice that is covalently bound to 
the fabric through the linker and spacer arm. As far as we know there are no 
commercially available first aid fabrics or haemostatic devices in which the biologically 
active molecule has been covalently linked to the fabric. Furthermore, in this first aid 
fabric the cleavable linker will be designed to cleave selectively only in the presence of 
blood. Through this distinct design the first aid fabric may deliver a number of different 
injury relevant pharmaceuticals to the wound site in a very efficient manner.  
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Figure 1.2. Design of a First Aid Smart Fabric 
 
 
The design of the event-specific cleavable linker of our first aid fabric required 
the most ingenuity on our part. It was quickly realized that the linker would have to meet 
some basic requirements. First, it would need to retain the proactive form of the drug so 
that the activity of the pharmaceutical agent would not be altered during binding or 
cleavage from the fabric. The linker would also ideally need to be stable to everyday 
conditions such as washing, heat, cold, rain, sweat, etc. Finally, while remaining stable 
under normal conditions, the linker must be able to be cleaved selectively in the presence 
of blood.   
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 In order to formulate the chemical composition of the cleavable linker we turned 
our attention to the unique chemoselective bond cleaving capabilities of blood. We 
envisioned that two different types of linkers could be designed, both of which would be 
selectively cleaved by blood (Figure 1.3). The first, a peroxide cleavable linker, would 
contain a peroxide functionality that could be acted upon by peroxidases and catalases, 
the body’s natural peroxide cleaving enzymes, which patrol the body protecting us from 
oxidative stress.24 Figure 1.3a illustrates how a peroxide functionalized linker could serve 
as an event-specific drug release tool. When blood comes into contact with the fabric, 
peroxidases or catalases present in the blood will cleave the peroxide functionality 
resulting in the formation of a carbamic acid. Loss of CO2 would result in a free amine 
that could serve as a nucleophile in an intramolecular cyclization event releasing the 
bound drug into the wound.  
 
 
 
 
 
 
 
 
 
 
                                                
24 Van Der Vliet, A.; Hu, M. L.; O’Neill, C. A.; Cross, C. E.; Halliwell, B. J. Lab. Clinic. Med. 1994, 124,  
   701. 
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Figure 1.3. First Aid Smart Fabric Cleavable Linker Design 
 
          Figure 1.3b illustrates the use of a serine protease sensitive peptide linker. In 
particular, we envisioned a peptide linker that would be selectively recognized by the 
serine protease thrombin as attractive because of the high concentration of thrombin 
present at the time of injury, due to its biological role in the body’s natural coagulation 
pathway.25 It is known that thrombin cleaves particular peptide sequences at the C-
terminus of an appropriately positioned Arg residue.26 Similarly to the peroxide linker, 
this cleavage would result in a functionalized pro-drug with a free amine moiety, which 
                                                
25 For an overview of the role of thrombin in hemostasis see: a) Davie, E. W.; Kulman, J. D. Thromb. 
 Hemost. 2006, 32, 3. b) Di Cera, E. Mol. Aspects Med. 2008, 29, 203. c) Tanka, K. A.; Key, N. S.; Levy, J. 
 H. Anesth. Analog. 2009, 108, 1433.   
26 Gallwitz, M. Enoksson, M.; Thorpe, M.; Hellman, L. PLos One. 2012, 7, e31756 and references therein.  
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could undergo an intramolecular cyclization to release the active form of the 
pharmaceutical.   
After some thought, we decided that the peptide linker would be more suitable for 
initial studies. Compared to the relatively reactive nature of peroxides, the amide bonds 
in peptides are considerably more stable. Since the linker of our first aid fabric must be 
stable to everyday conditions including light, heat, and the slightly basic nature of 
laundry detergents, a peptide linker seemed more suitable. Furthermore, a literature 
search for the peroxy carbamic acid functionality that we envisioned installing into our 
peroxide linker, revealed that very little is known about how to synthesize such molecules. 
On the other hand, peptide coupling chemistry is a well established field.27 It is our hope 
that after some preliminary developments have been made on this project, we can turn 
our attention to synthesizing and testing the novel peroxy carbamic acid functionalized 
linker.     
 In the initial stage of this project we hoped to accomplish a proof of concept.  
For convenience and ease of operation at this early phase in the first aid smart fabric 
synthesis several changes were made to the original design.  Instead of using cotton 
fabric, we opted for Whatman type 1 cellulose filter paper, which is readily available in 
the laboratory. Since cotton fabric consists of 90% cellulose, the filter paper was deemed 
an appropriate substitute. In addition, a coumarin derivative fluorescent probe was chosen 
to mimic the drug portion of the first aid fabric. The coumarin derivative is well suited 
                                                
27 For an overview of peptide coupling chemistry see: a) Montalbetti, C. A. G. N.; Falque, V. Tetrahedron    
   2005, 61, 10827. b) Valeur, E.; Bradley, M.; Chem. Soc. Rev. 2009, 38, 606. c) El-Faham, A.; Albericio,  
   F. Chem. Rev. 2011, 111, 6557. d) Al-Warhi, T. I.; Al-Hazimi, H. M. A.; El-Faham, A. J. Saudi Chem. 
   Soc. 2012, 16, 97.   
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for our initial studies because its fluorescent nature allows us to visually determine 
whether the drug mimic has been attached or cleaved from our first aid fabric.   
 
1.4 Installation of the Spacer Arm 
Synthesis of the first aid fabric began with the functionalization of the cellulose 
filter paper with a spacer arm. The installation of the spacer arm was deemed necessary to 
reduce any steric hindrance that may prevent proper thrombin binding and cleavage of 
the peptide linker if the linker was to be situated too close to the solid support.  To install 
the spacer, 4 cm Whatman type 1 cellulose filter paper was reacted with epichlorohydrin 
and pentaethylenehexamine (PEHA) in 2% NaOH (Scheme 1.1). Following the reaction 
the paper was thoroughly rinsed with excess 2% NaOH. Since this reaction is run on filter 
paper it is difficult to use NMR spectroscopy to assess conversion, so an alternative 
method was established to determine if the reaction had occurred successfully. This was 
accomplished by staining the filter paper with ninhydrin. The ninhydrin stain reacts with 
primary amines to form imine complex 1.6 which is purple in color (Scheme 1.2). Indeed, 
we saw that staining the derivatized cellulose filter paper colored the paper purple, 
indicating that the reaction had occurred successfully.  
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Scheme 1.1. Functionalization of Cellulose Filter Paper 
 
 
Next, to link the cellulose filter paper-spacer arm adduct to the thrombin selective 
peptide chain, a compatible functional group needed to be installed at the spacer arm 
terminus. Addition of a carboxylic acid moiety to the terminus of the spacer arm would 
allow for easy coupling to the N-terminus of the peptide chain. Installation of the 
carboxylic acid moiety was accomplished through reaction of the derivatized filter paper 
with succinic anhydride (Scheme 1.1). After washing the functionalized filter paper with 
ammonium chloride in order to insure full protonation, the paper was stained with 
bromocresol green. The yellow color that formed indicated the presence of an acidic 
functionality (pH < 5.4) and confirmed that the reaction had occurred successfully. 
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Scheme 1.2. Reaction of Primary Amines with Ninhydrin 
 
 
 Before moving forward with the synthesis of our peptide linker, we thought that it 
would be beneficial to test whether the fluorescent probe drug mimic could be 
successfully attached and cleaved from the functionalized cellulose. This would also 
allow us to begin to gather data about loading amounts. To accomplish this task we began 
by functionalizing commercially available 7-hydroxy-4-methylcoumarin with a reactive 
handle (Scheme 1.3). The etherification of coumarin 1.7 with 2-bromoethanol provided 
us with functionalized fluorescent probe 1.8 in excellent yield. 
 
Scheme 1.3. Synthesis of a Fluorescent Probe 
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Conditions for the coupling of probe 1.8 with functionalized filter paper 1.2 were 
previously optimized by Valerie Angell.1 Synthesis of the fluorescent coupled filter paper 
1.9 was accomplished through reaction of probe 1.8 and filter paper 1.2 with DMAP and 
EDC in pyridine (Scheme 1.4). Coupling was confirmed by observation of fluorescence 
when coupled filter paper 1.9 was exposed to UV light.   
 
Scheme 1.4. Attachment of Fluorescent Probe to Spacer Arm 
 
 
In order to get a quantitative measure of the amount of fluorescent probe drug 
equivalent that was coupled to the filter paper, cleavage conditions to remove the probe 
were also explored. Angell found that 3 M KOH and heating the reaction to 50 °C was 
required in order to cleave functionalized probe 1.8 from filter paper 1.9. Successful 
cleavage was confirmed through observation that the filter paper no longer glowed under 
UV light. It is important to note that less basic conditions such as 1M KOH did not lead 
to successful cleavage. Since one of the requirements for our smart fabric is that it cannot 
prematurely release the drug under everyday conditions such as washing, it is 
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encouraging to see that slightly basic conditions, such as those found in detergents, do not 
seem to cleave the fluorescent probe from the paper.  
 
1.5 Synthesis of the Peptide Linker 
 With the synthesis of the functionalized cellulose paper completed, our attention 
was turned to the design and synthesis of a thrombin selective peptide linker. A six amino 
acid peptide Leu-Val-Pro-Arg-Gly-Ser was chosen because it is a known thrombin 
substrate.26 We envisioned that cleavage of the Arg-Gly peptide bond would release the 
functionalized proactive drug from the solid fabric support (Figure 1.3b). Intramolecular 
cyclization would then result in the formation of a thermodynamically favorable six 
membered diketopiperizine ring and release of the free biologically active molecule.  
 
1.5.1 Synthesis of a Leu-Val-Pro-Arg-Gly-Ser Peptide Linker 
 Due to the fact that we did not possess a solid phase peptide synthesizer in our 
laboratory, synthesis of the hexapeptide was first attempted in solution phase. We were 
hopeful that the coupling of only six amino acids could be efficiently accomplished in 
solution phase. The synthesis was begun by coupling fluorescent probe 1.8 to Fmoc-
Ser(t-Bu)-OH using HBTU (Scheme 1.5). Deprotection of the resulting Fmoc protected 
adduct with TAEA yielded crude compound 1.10, which was used in the subsequent 
coupling with Fmoc-Gly without further purification. Deprotection of the N-terminus of 
1.11 was then attempted with tris(2-aminoethyl)amine (TAEA); however, NMR of the 
crude product only showed the presence of fluorescent probe 1.8. It was hypothesized 
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that once the free amine functionality of 1.12 was uncovered it quickly cyclized to form a 
diketopiperizine ring and the free fluorescent probe.  
 
Scheme 1.5. Synthesis of Gly-Ser-Probe 
 
 
The synthetic plan was altered to circumvent the cyclization issue. Instead of 
building the peptide chain from the C-terminus, synthesis of the Leu-Val-Pro-Arg-Gly 
pentapeptide would be accomplished first. This pentapeptide would then be coupled to 
Ser-probe 1.10. The synthesis of the pentapeptide began with the successful coupling of 
glycine benzyl ester 1.13 with Fmoc-Arg(Pbf)-OH (Scheme 1.6). However, similarly to 
the deprotection of 1.11 above, subsequent deprotection with TAEA to form dipeptide 
1.15, gave diketopiperizine 1.16 as the only isolated product. The cyclization of N-
terminus deprotected dipeptides in the presence of a good leaving group at the carboxy 
terminus has been well documented in the literature,28 so this result did not come as a 
surprise.    
                                                
28 a) Bodanszky, M.; Martinez, J. Synthesis. 1981, 5, 333. b) Ward, D. E.; Lazny, R.; Pedras, M. S. C. 
Tetrahedron Lett. 1997, 38, 339.  
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Scheme 1.6. Synthesis of Arg-Gly Dipeptide 
 
 
It was hypothesized that a bulky protecting group, such as t-butyl, on the C-
terminus of the dipeptide would prevent diketopiperizine formation (Scheme 1.7). 
Cyclization would not readily occur because of the unavoidable syn-pentane interactions 
in tetrahedral intermediate 1.18, which would be generated during such a process. With 
this new strategy in mind, attempts to synthesize the Leu-Val-Pro-Arg-Gly pentapeptide 
were renewed with vigor.    
 
Scheme 1.7. Undesirable Syn-Pentane Interactions in the Cyclization of a t-Butyl Ester 
Protected Dipeptide 
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 Indeed, coupling of glycine t-butyl ester hydrochloride with Fmoc-Arg(Pbf)-OH 
using EDC and HOBt  followed by deprotection with TAEA yielded desired dipeptide 
1.22 in good yield (Scheme 1.8). Coupling of a tosyl protected arginine gave similar 
yields. Although deprotected dipeptide 1.23 could be isolated in good yield, work-up and 
purification of the deprotected product proved tedious and did not give consistent results. 
Other methods for Fmoc deprotection were thus explored. 
 
Scheme 1.8. Successful Synthesis of Arg-Gly Dipeptide Using a Bulky C-Terminus 
Protecting Group 
 
Standard Fmoc deprotection conditions, in solid phase peptide synthesis, consist 
of a large excess of secondary amine such as piperidine in DMF (Scheme 1.9).29 In this 
case, the piperidine functions as both a base to cleave off the Fmoc group and as a 
scavenger to trap the dibenzofulvene (DBF) byproduct that forms during reaction. Excess 
base is necessary to outcompete addition of primary amines on the deprotected peptide 
into the DBF byproduct. Excess base and the scavenged DBF byproduct can then be 
removed with several washes of organic solvent. However, such conditions are not 
                                                
29 Isidro-Llobet, A.; Álvarez, M.; Albericio, F. Chem. Rev. 2009, 109, 2455.  
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suitable for liquid phase peptide synthesis because of the low volatility of DMF, the 
solvent-dependent reversible scavenging of DBF by piperidine, and DBF polymerization 
at high concentrations. Furthermore, separation of the desired product from the excess 
base and DBF-piperidine adduct is often difficult.   
 
Scheme 1.9. Piperidine Deprotection of Fmoc 
 
 
Although Fmoc deprotection methods suitable for solution phase peptide 
synthesis are largely unexplored, a few methods have been published.30,31,32 In 1990, 
Carpino and co-workers reported that TAEA in DCM could be used for Fmoc 
deprotection.30 The DBF-TAEA adduct could be easily removed from the desired peptide 
by washing the crude reaction mixture with a pH 5.5 phosphate buffer. This Fmoc 
                                                
30 Carpino, L. A.; Sadat-Aalaee, D.; Beyermann, M. J. Org. Chem. 1990, 55, 1673. 
31 Sheppeck II, J. E.; Kar, H.; Hong, H. Tetrahedron Lett.  2000, 41, 5329. 
32 Flegel, M.; Flegelova, Z.; Malon, P.; Klenerova, V.; Hynie, S.  Collection Symposium Series. 2011, 13, 
    41. 
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deprotection strategy was used in our initial peptide linker synthesis studies. However, 
although removal of highly volatile DCM was not an issue, washing with the phosophate 
buffer sometimes led to undesirable emulsions or incomplete removal of the DBF-TAEA 
adduct. Incomplete scavenging was also sometimes an issue.   
Ideally, separating the roles of base and scavenger in the reaction should facilitate 
the isolation of the deprotected peptide. In 2000, Sheppeck’s group reported a new 
convenient method for solution phase removal of the Fmoc group using 3 mol% DBU 
and octanethiol in THF.31 Use of DBU, a non-nucleophilic, base that is stronger than 
piperidine, allowed for the use of only a catalytic amount of base. Excess octanethiol, 
which is known to be a superior nucleophile in conjugate additions and thus a more 
efficient DBF scavenger than piperidine, was also added. Removal of DBU, left over 
octanethiol, and the thiol-DBF adduct was easily accomplished by trituration or 
recrystallization from diethyl ether. 
Lastly, Flegel and coworkers reported an analogous method for Fmoc 
deprotection in 2011.32 They utilized a similar thiol, 1-octadecanethiol (C-18-SH), to 
scavenge the DBF byproduct. tert-Butyl amine (TBA), also a non-nucleophilic strong 
base, could be used as the solvent or as a 30% TBA solution in DCM. Due to the low 
boiling point of TBA (46 °C) removal of excess base was not a problem. Isolation of the 
pure desired peptide was easily accomplished by precipitation from diethyl ether or 
heptane.  
These known solution phase deprotection methods were tested on Arg-Gly 
dipeptides 1.22 (Scheme 1.10). Reaction time, ease of work up and product purification 
were all taken into consideration. We found that using 20% piperidine in DCM (a less 
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volatile solvent) led to long reaction times (eight hours) incomplete scavenging of the 
DBF and difficulties in purification (entry 1). As mentioned earlier, while TAEA did 
provide good yield of the desired product, difficult to handle emulsions and inconsistent 
scavenging proved this method to be less than ideal (entry 2). Use of DBU with a thiol 
DBF scavenger led to good yield, but longer reaction times (5 hours) and difficulties in 
isolating the product totally pure (entry 3). Finally, using 30% TBA and five equivalents 
of C-18-SH we were able to isolate the pure desired product 1.23 in 93% yield through 
trituration with diethyl ether (entry 5). With two to three hour reaction times and no 
complications during workup or purification we deemed this method to be the most 
successful.  
 
Scheme 1.10. Deprotection Conditions Screen 
 
Entry Conditions Reaction Time Yield 
1 20% piperidine, DCM 8 hr hard to purify 
2 30% TAEA, DCM 1 hr 90% 
3 3% DBU, CH3(CH2)17SH, THF 5 hr 98% (not clean) 
4 100% TBA, CH3(CH2)17SH 1 hr 74% 
5 30% TBA, CH3(CH2)17SH, DCM 3 hr 93% 
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With superior Fmoc deprotection conditions in hand we moved forward with the 
synthesis of our Leu-Val-Pro-Arg-Gly pentapeptide (Scheme 1.11). Proline was the next 
amino acid to be coupled. Luckily, our standard coupling conditions, EDC and HOBt in 
DCM provided the desired protected Pro-Arg-Gly tripepide 1.29 in good yield. 
Deprotection of 1.29 with our newly established Fmoc cleavage conditions yielded 
deprotected tripeptide 1.30 in 91% yield.  
 
Scheme 1.11. Synthesis of Pro-Arg-Gly Tripeptide 
 
 
Coupling of the fourth amino acid, valine, proved to be a little more challenging 
(Scheme 1.12). Preliminary data, including mass spectrometry confirmation, showed that 
standard EDC, HOBt conditions did provide the desired product 1.31. However, the 
reaction was not clean, and the crude product was difficult to purify. A crude yield (30%) 
was taken for preliminary information. The low yield and messy reaction outcome was 
not completely surprising to us, since the secondary amine of proline is more sterically 
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hindered than the primary amine of other amino acids. Likely, several different coupling 
conditions would need to be tested before successful coupling of the valine could be 
achieved. However, at this point in the project, synthesis of the pentapeptide was put on 
hold due to the discovery of a new direction for a shorter peptide linker design. 
 
Scheme 1.12. Synthesis of Val-Pro-Arg-Gly Tetrapeptide 
 
 
1.5.2 Synthesis of a Val-Pro-Arg Peptide Linker 
A serendipitous Friday afternoon Google search for “thrombin substrates” 
provided us with new insight into our event-specific cleavable linker design. It was 
discovered that Boc-Val-Pro-Arg-AMC 1.32 (Figure 1.4) was a commercially available 
thrombin substrate sold by Aldrich, as well as other chemical companies. A more detailed 
search in the literature33 showed that this fluorogenic substrate is highly specific for       
α-thrombin and has been extensively used in biological and biochemical thrombin assays. 
It is known that thrombin cleaves at the C-terminus of the arginine subunit of 1.32 
releasing the 7-amino-4-methylcoumarin fluorescent probe from the tripeptide.  
 
                                                
33 a) Morita, T.; Kato, H.; Iwanaga, S.; Takada, K.; Kimura, T.; Sakakibara, S. J. Biochem. 1977, 82, 1495.  
    b) Board, P. G. Ann. Hum. Genet. 1982, 46, 293. c) Nakamura, S. J. Biochem. 1985, 97, 705.   
    d) Kawabata, S.; Morita, T.; Iwanaga, S.; Igarashi, H. J. Biochem. 1985, 97, 1073.   
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Figure 1.4. Commercially Available Thrombin Substrate 
 
  
We were excited about this find because not only did this thrombin substrate 
consist of a shorter peptide chain, but it also contained the same type of coumarin 
derivative fluorescent probe that we had planned to use as our drug mimic. With this 
exciting new direction in mind we set our sights on synthesizing a Val-Pro-Arg-AMC 
cleavable peptide linker.  
 Due to our previous experience with the difficulty of proline peptide coupling, we 
began the synthesis of our new peptide with the coupling of Boc-Val-OH and H-Pro-
OMe hydrochloride (Scheme 1.13). To our delight, our standard coupling conditions 
(EDC, HOBt) gave us the desired dipeptide 1.35 in 91% yield. In order to couple this 
dipeptide to arginine, the C-terminus was deprotected under standard saponification 
conditions.  
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Scheme 1.13. Synthesis of Val-Pro Dipeptide 
 
  
With dipeptide 1.36 in hand, we turned our attention to the synthesis of the Arg-
AMC subunit. Commercially available thrombin substrate 1.32 does not contain a 
protecting group on the arginine side chain due to the necessity of the free guanidino 
moiety for proper binding to thrombin’s active site. However, in order to avoid 
complications during peptide synthesis a tosyl protected arginine was chosen for coupling. 
Later, deprotection of the arginine side chain would reveal the necessary functionality for 
proper enzyme binding.  
Activation of Boc-Arg(Tos)-OH 1.37 with phosphorous oxychloride, followed by 
coupling with 7-amino-4-methylcoumarin yielded the desired Arg-AMC subunit 1.39 in a 
modest yield of 54% (Scheme 1.14). Optimization of this coupling step was temporarily 
postponed in order to continue progress on the synthesis of the complete peptide linker.  
Standard deprotection of 1.39 with trifluoroacetic acid (TFA) in dichloromethane gave 
TFA salt 1.40. Due to the more stable nature of the TFA salts of these amino acids, 1.40 
was used directly in the next step.  
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Scheme 1.14. Synthesis of Arg-AMC 
 
  
With the Boc-Val-Pro-OH dipeptide 1.36 and the Arg-AMC subunit 1.40 in hand 
coupling of these two moieties was attempted (Scheme 1.15). TFA salt 1.40 was pre-
stirred with DIPEA for 15 minutes in order to generate the free amine in situ. Subsequent 
addition of Boc-Val-Pro-OH 1.36 and the necessary coupling agents generated the 
desired product 1.41 in a fantastic 91% yield. At this point only deprotection of the 
arginine side chain of 1.41 is necessary in order to achieve the synthesis of the thrombin 
selective substrate 1.32. However, because coupling of 1.41 to the functionalized 
cellulose paper still needs to be completed, the tosyl group was not removed at this point. 
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Scheme 1.15. Synthesis of Boc-Val-Pro-Arg(Tos)-AMC 
 
 
1.6 Synthesis of a Complete First Aid Smart Fabric 
 At this point in the project successful attachment of a spacer arm to the cellulose 
filter paper through functionalized of the cellulose has been realized. Synthesis of a 
thrombin selective peptide linker coupled to a fluorescent probe drug mimic has also 
been achieved. Completion of the first aid fabric synthesis now requires only joining of 
these two major components. We envisioned that after standard Boc deprotection of 
peptide linker 1.41, functionalized cellulose 1.2 and deprotected peptide linker 1.42 could 
be coupled together using either EDC and HOBt, or another set of standard peptide 
coupling conditions (Scheme 1.16). Successful coupling could be visually confirmed 
through UV irradiation of the resulting coupled fabric 1.43.   
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Scheme 1.16.  Proposed Synthesis of a Protected First Aid Fabric 
 
 
Finally, deprotection of the arginine side chain would be necessary for proper 
binding of the tripeptide into the thrombin active site.  This deprotection could be 
accomplished with HF, TFMSA-TFA-thioanisole, or Na/NH3 to give the desired first aid 
smart fabric 1.44 (Scheme 1.17).29   
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Scheme 1.17. Proposed Deprotection of the Arginine Side Chain of the First Aid Fabric 
 
 
1.7 Future Research 
After synthesis of first aid smart fabric 1.44 is accomplished, the proof of concept 
phase of this project will be completed by testing the first aid fabric with thrombin to 
assess if cleavage of the fluorescent probe drug mimic occurs. In addition, loading of the 
drug mimic on the filter paper will be assessed through fluorescence studies. Subsequent 
research will aim at determining and optimizing the distance provided by the spacer arm 
as well as testing the stability of the cleavable linker under every day conditions such as 
sunlight, heat and washing detergent.  
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1.8 Experimental 
 
1.8.1 General Information 
Proton nuclear magnetic resonance spectra (1H-NMR) were measured on a Varian 
Gemini-400 (400 MHz), a Varian Gemini-500 (500 MHz), or a Varian Inova-500 (500 
MHz) spectrometer. Chemical shifts are reported in ppm downfield from 
tetramethylsilane with the solvent resonance as the reference (CDCl3: δ 7.26 ppm). Data 
are reported as follows: chemical shift, multiplicity (s =singlet, d = doublet, t = triplet, q 
= quartet, br = broad, m = multiplet), coupling constants (Hz), and integration. Carbon 
nuclear magnetic resonance spectra (13C-NMR) were recorded on a Varian Gemini-400 
(100 MHz), or a Varian Gemini-500 (125 MHz) spectrometer with complete proton 
decoupling. Chemical shifts are reported in ppm downfield from tetramethylsilane with 
the solvent resonance as the reference (CDCl3: δ 77.23 ppm). Infrared (IR) spectra were 
recorded on a Mattson Galaxy series FTIR and are reported in wave numbers (cm-1). 
Bands are characterized as broad (br), strong (s), medium (m), or weak (w). High 
resolution mass spectral analyses (HRMS) were performed by Marek Domin, Mass 
Spectrometry Laboratory, at Boston College. Melting points (mp) were obtained with a 
Melt-Temp and are reported uncorrected. 
Starting materials and reagents were purchased from commercial suppliers and 
used without further purification, unless otherwise specified and except the following: 
Dry dichloromethane (DCM) and tetrahydrofuran (THF) were used from a solvent 
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purification system.34 All oxygen- or moisture-sensitive reactions were carried out under 
N2 atmosphere in oven-dried (140 °C, >24 h) or flame-dried glassware. Air- or moisture-
sensitive liquids were transferred by syringe and were introduced into the reaction flasks 
through rubber septa. Degassing refers to a flow of dry N2 (g) bubbling through reaction 
solvent. Unless otherwise stated, reactions were stirred with a Teflon covered stir bar. 
Concentration refers to the removal of solvent using a rotary evaporator followed by use 
of a vacuum pump at approximately 1 torr. Silica gel column chromatography refers to 
flash chromatography35 and was performed using 60 Å (230-400 Mesh ASTM) silica gel 
purchased from Silicycle. Thin layer chromatography was performed on glass back 60 Å 
(250 um thickness) silica gel plates purchased from Silicycle.  
 
1.8.2 Experimental Procedures36 
 
Derivatized Cellulose Filter Paper (1.1)     
 
 Grade 1 Whatman filter paper (4.0 cm), 2% NaOH (10.0 mL) and pentaethylene 
hexamine (400 µL) were combined with stirring in a 100 mL beaker. After slowly heating 
the reaction to 50 °C, epichlorohydrin (550 µL) and NaBH4 were added. The reaction 
                                                
34 Panborn, A.B.; Giardello, M.A.; Grubbs, R.H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 12,     
aa1512.                                  
35 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923. 
36 For more characterization data, supporting information, and experimental procedures not found here see:  
    Monoalkylation of 1,2-Diols and Design and Synthesis of First Aid Smart Fabrics, Angell, V. L. Masters 
    Thesis, Department of Chemistry, Boston College, 2012. 
 
36
  
mixture was covered with parafilm and allowed to stir at 50 °C for 4 hours. After cooling 
to room temperature, the filter paper was rinsed with 2% NaOH solution (100 mL) and 
allowed to dry. A small portion of the paper was then cut off and stained with ninhydrin 
to insure positive coupling. 
 
Functionalized Cellulose Filter Paper (1.2)    
 
 Derivatized filter paper 1.1, succinic anhydride (207 mg), and pyridine (6.00 mL) 
were combined with stirring in a 100 mL beaker. The reaction was covered with parafilm 
and stirred for 12 hrs. The filter paper was removed from the beaker and washed with 
pyridine (25 mL), DCM (25 mL), and saturated aqueous ammonium chloride solution (25 
mL). Once dry, a small portion of the paper was cut off and stained with bromocresol 
green to ensure positive coupling.  
(S)-tert-butyl-2-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-(3-
tosylguanidino)pentanamido)acetate (1.21) 
 
Glycine tert-butyl ester hydrochloride (15.2 mg, 0.0907 mmol, 1.0 equiv.) and 
DIPEA (15.8 µL, 0.0907 mmol, 1.0 equiv.) were combined in an oven dried vial under 
37
  
N2. DCM (1.00 mL) was added and the reaction allowed to stir for 15 minutes. Fmoc-
Arg(Tos)-OH (50.0 mg, 0.0907 mmol, 1.0 equiv.) was then added to the reaction vial, 
followed immediately by EDC·HCl (19.2 mg, 0.0998 mmol, 1.1 equiv.) and HOBt (13.5 
mg, 0.0998 mmol, 1.1 equiv.) The vial was then capped, to ensure a constant 
concentration, and the reaction mixture was allowed to stir overnight.  TLC analysis (5:1 
ethyl acetate:hexanes, UV visualization) indicated complete consumption of starting                     
Fmoc-Arg(Tos)-OH so the reaction was quenched with 1 M HCl (2 mL). The organic 
layer was then washed with aqueous sodium bicarbonate (3 mL), dried over MgSO4, 
filtered, and concentrated. The crude yellow solid was purified by silica gel flash 
chromatography (1:1 ethyl acetate:hexanes to 5:1 ethyl acetate:hexanes) to afford 56.0 
mg (93%) of 1.21 as a white solid. 1H NMR (500 MHz, CDCl3): δ 7.75-7.73 (m, 4H), 
7.58-7.55 (m, 2H), 7.38-7.35 (m, 2H), 7.27-7.24 (m, 2H), 7.17 (d, J=7.8 Hz, 2H), 6.46 (br, 
2H), 6.13 (br, 1H), 4.33-4.32 (m, 3H), 4.17-4.14 (m, 1H), 3.95 (dd, J=17.8, 5.4 Hz, 1H), 
3.81 (dd, J=17.6, 5.1 Hz, 1H), 3.34-3.21 (m, 2H), 2.34 (s, 3H), 1.93-1.85 (m, 1H), 1.73-
1.64 (m, 1H), 1.63-1.54 (m, 2H), 1.42 (s, 9H); DART-HRMS (m/z): Calc’d for [M+H]+ 
(C34H41N5O7S): 664.2799 ; Found: 664.2818.  
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(S)-tert-butyl 2-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-(3-((2,2,4,6,7-
pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentanamido)acetate 
(1.22) 
 
Glycine tert-butyl ester hydrochloride (258 mg, 1.54 mmol, 1.0 equiv.) and 
DIPEA (268 µL, 1.54 mmol, 1.0 equiv.) were combined in a flame dried 25 mL round 
bottom flask under N2. DCM (6.20 mL) was added and the reaction allowed to stir for 15 
minutes. Fmoc-Arg(Pbf)-OH (1.00 g, 1.54 mmol, 1.0 equiv.) was then added to the 
reaction vial, followed immediately by EDC·HCl (325 mg, 1.70 mmol, 1.1 equiv.) and 
HOBt (229 mg, 1.70 mmol, 1.1 equiv.) The reaction mixture was allowed to stir for 15 
hours until TLC analysis (5:1 ethyl acetate:hexanes, UV visualization) indicated 
complete consumption of starting Fmoc-Arg(Pbf)-OH. The reaction was quenched with 1 
M HCl (15 mL). The organic layer was then washed with saturated aqueous sodium 
bicarbonate (25 mL), dried over MgSO4, filtered, and concentrated. The crude yellow 
solid was purified by silica gel flash chromatography (5:1 ethyl acetate:hexanes) to afford 
1.03 g (88%) of 1.22 as a white solid. 1H NMR (500 MHz, CDCl3): δ 7.71 (d, J=7.6 Hz, 
2H), 7.56-7.54 (m, 2H), 7.51 (br, 1H), 7.36-7.33 (m, 2H), 7.25-7.21 (m, 2H), 6.36 (br, 
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2H), 6.15 (br, 2H), 4.35-4.30 (m, 3H), 4.14-4.12 (m, 1H), 3.95 (dd, J=17.8, 5.6 Hz, 1H), 
3.80 (dd, J=17.8, 5.4 Hz, 1H), 3.35-3.19 (m, 2H), 2.90 (s, 2H), 2.58 (s, 3H), 2.50 (s, 3H), 
2.06 (s, 3H), 1.96-1.91 (m, 1H), 1.78-1.70 (m, 1H), 1.66-1.57 (m, 2H), 1.42 (s, 6H), 1.41 
(s, 9H); DART-HRMS (m/z): Calc’d for [M+H]+ (C40H51N5O8S): 762.3531; Found: 
762.3541. 
 
(S)-tert-butyl 2-(2-amino-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-
yl)sulfonyl)guanidino)pentanamido)acetate (1.23) 
 
 Compound 1.22 (34.8 mg, 0.0456 mmol, 1.0 equiv.), TAEA (342 µL, 2.28 mmol, 
50 equiv.), and dry DCM (1.00 mL) were combined in a small vial under N2. The reaction 
was stirred until TLC analysis indicated complete consumption of starting material 1.22 
(1 hr). The reaction mixture was then diluted with DCM, washed with saturated aqueous 
sodium chloride (2x10 mL), pH 5.5 phosphate buffer (2x10 mL), and the organic layer 
was dried over MgSO4, filtered and concentrated. The resulting pure white solid 1.23 was 
obtained in 22.4 mg (90%).  
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Alternatively, starting material 1.22 (1.03 g, 1.35 mmol, 1.0 equiv) and                  
1-octadecanethiol (465 mg, 1.62 mmol, 1.2 equiv.) were combined with dry DCM (27.0 
mL) in a small vial under N2. tert-Butylamine (8.10 mL, 30% in DCM) was then added 
dropwise to the stirring reaction mixture.  The crude reaction mixture was concentrated 
after TLC analysis indicated complete consumption of starting material 1.22 (3 hrs). The 
resulting sticky solid was recrystallized from diethyl ether to afford 680 mg (93%) of 
1.23 as a pure white solid. 1H NMR (500 MHz, CDCl3): δ 7.82 (br, 1H), 6.19 (br, 3H), 
3.91 (dd, J=5.6, 2.0 Hz, 2H), 3.62-3.55 (m, 1H), 3.29-3.14 (m, 2H), 2.95 (s, 2H), 2.56 (s, 
3H), 2.52 (s, 3H), 2.09 (s, 3H), 1.84-1.68 (m, 4H), 1.46 (s, 6H), 1.45 (s, 9H). DART-
HRMS (m/z): Calc’d for [M+H]+ (C25H41N5O6S): 540.2856; Found: 540.2861. 
 
(S)-(9H-fluoren-9-yl)methyl 2-(((S)-1-((2-(tert-butoxy)-2-oxoethyl)amino)-1-oxo-5-
(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentan-2-
yl)carbamoyl)pyrrolidine-1-carboxylate (1.29) 
 
H-Arg(Pbf)-Gly-OtBu 1.23 (170 mg, 0.320 mmol, 1.0 equiv.) and Fmoc-Pro-OH 
(106 mg, 0.320 mmol, 1.0 equiv.) were combined in an oven dried vial under N2. DCM 
(1.30 mL) was added followed by EDC·HCl (66.5 mg, 0.352 mmol, 1.1 equiv.) and 
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HOBt (47.0 mg, 0.352 mmol, 1.1 equiv.) The vial was then capped, to ensure a constant 
concentration, and the reaction mixture was allowed to stir for 16 hours. TLC analysis 
(9:1 ethyl acetate:hexanes, UV visualization) indicated complete consumption of starting 
Fmoc-Pro-OH. The reaction was quenched with 1 M HCl (3 mL). The organic layer was 
then washed with saturated aqueous sodium bicarbonate (5 mL), dried over MgSO4, 
filtered, and concentrated. The crude solid was purified by silica gel flash 
chromatography (9:1 ethyl acetate:hexanes) to afford 240 mg (89%) of 1.29 as a white 
solid. 1H NMR (500 MHz, CDCl3): δ 8.05 (br, 0.5H), 7.72 (d, J=7.3 Hz, 2H), 7.57-7.51 
(m, 2H), 7.39-7.33 (m, 3H), 7.29-7.25 (m, 2H), 6.24-6.10 (br, 3H), 4.53-4.48 (m, 1H), 
4.37 (dd, J=8.3, 3.9 Hz, 1H), 4.29 (dd, J=10.3, 6.9 Hz, 1H), 4.16-4.01 (m, 2H), 3.91 (qd, 
J=18.1, 5.4 Hz, 1H), 3.78-3.73 (m, 1H),  3.56-3.53 (m, 1H), 3.35-3.18 (m, 2H), 2.83 (s, 
2H), 2.55 (s, 3H), 2.48 (s, 3H), 2.28-2.22 (m, 1H), 2.14-1.92 (m, 5H), 2.08 (s, 3H), 1.79-
1.75 (m, 1H), 1.64-1.54 (m, 2H), 1.45 (s, 9H), 1.36 (m, 6H). 13C NMR (100 MHz, 
CDCl3): δ 173.10, 172.38, 168.82, 158.80, 156.46, 155.97, 144.26, 143.82, 141.40, 
141.37, 138.34, 133.22, 132.19, 127.90, 127.86, 127.28, 127.19, 125.37, 125.31, 124.72, 
120.13, 117.69, 86.42, 82.00, 67.92, 61.04, 47.39, 47.17, 43.35, 42.26, 40.64, 30.78, 
29.89, 28.85, 28.71, 28.24, 26.29, 24.70, 19.51, 18.15, 12.61.  IR (KBr thin film): 3431 
(br), 3333 (br), 2975 (m), 2932 (m), 1678 (m), 1550 (m), 1156 (s), 1108(s), 1092 (s) 910 
(m), 591 (s). DART-HRMS (m/z): Calc’d for [M+H]+ (C45H58N6O9S): 859.4059; Found: 
859.4062. 
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tert-Butyl 2-((S)-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-
yl)sulfonyl)guanidino)-2-((S)-pyrrolidine-2-carboxamido)pentanamido)acetate 
(1.30) 
 
Starting tripeptide 1.29 (20.0 mg, 0.0233 mmol, 1.0 equiv) and 1-octadecanethiol 
(8.00 mg, 0.0279 mmol, 1.2 equiv.) were combined with dry DCM (0.500 mL) in a small 
vial under N2. tert-butylamine (140 µL, 30% in DCM) was then added dropwise to the 
stirring reaction mixture.  The reaction mixture was concentrated after TLC analysis 
indicated complete consumption of starting material 1.29 (2.5 hrs). The resulting crude 
solid was triturated with diethyl ether (2x1 mL) to afford 13.4 mg (91%) of 1.30 as a pure 
white solid. (mp 106-108 °C). 1H NMR (500 MHz, CDCl3): δ 8.30 (d, J=8.3 Hz, 1H), 
7.57 (br, 1H), 6.37 (br, 1H), 6.32 (br, 2H), 4.53 (m, 1H), 3.93 (dd, J=17.6, 5.9 Hz, 1H), 
3.82 (dd, J=17.6, 5.4 Hz, 1H),  3.75 (dd, J=8.8, 5.4 Hz, 1H), 3.33-3.19 (m, 2H), 3.02-2.92 
(m, 2H), 2.94 (s, 2H), 2.57 (s, 3H), 2.50 (s, 3H), 2.15-2.08 (m, 1H), 2.08 (s, 3H), 1.96-
1.91 (m, 1H), 1.86-1.80 (m, 1H), 1.74-1.67 (m, 3H), 1.63-1.56 (m, 1H), 1.52-1.45 (m, 
1H), 1.45 (s, 6H), 1.44 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 176.05, 172.28, 169.39, 
158.92, 156.67, 138.59, 133.15, 132.51, 124.78, 117.67, 86.56, 82.36, 60.63, 51.96, 47.42, 
43.46, 42.10, 40.69, 31.14, 30.87, 28.81, 28.27, 26.34, 25.25, 19.48, 18.14, 12.68. IR 
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(KBr thin film): 3438 (br), 3327 (br), 2975 (m), 2934 (m), 1741 (w), 1650 (m), 1551 (s), 
1369 (w), 1245 (w), 1156 (m), 1107 (w) 734 (w), 664 (w). DART-HRMS (m/z): Calc’d 
for [M+H]+ (C30H48N6O7S): 637.3378; Found: 637.3381. 
   
(S)-methyl 1-((S)-2-((tert-butoxycarbonyl)amino)-3-methylbutanoyl)pyrrolidine-2-
carboxylate (1.35)    
 
DIPEA (3.20 mL, 18.4 mmol, 4.0 equiv.) was added dropwise to a stirring 
solution of Proline methyl ester hydrochloride (762 mg, 4.60 mmol, 1.0 equiv.) in dry 
DCM (23.0 mL) at 0 °C under N2. After stirring for 20 minutes, Boc-Val-OH (1.00 g, 
4.60 mmol, 1.0 equiv.), EDC·HCl (1.24 g, 6.44 mmol, 1.4 equiv.) and HOBt (870 mg, 
6.44 mmol, 1.4 equiv.) were added at 0 °C. The reaction was allowed to warm up slowly 
while stirring overnight. The reaction was quenched with 1 M HCl (20 mL), the layers 
were separated, and the organic layer was washed with saturated aqueous sodium 
bicarbonate (50 mL), dried over Na2SO4, filtered, and concentrated. The crude product 
was purified by silica gel column chromatography (6:1 ethyl acetate:hexanes) to give 
1.44 g (91%) of dipeptide 1.35 as a viscous light yellow oil consistent with known 
spectroscopic data.37 1H NMR (500 MHz, CDCl3): δ 5.19 (d, J = 9.3 Hz, 1H), 4.53 (dd, J 
= 8.8, 4.9 Hz, 1H), 4.28 (dd, J=9.3, 6.3 Hz, 1H), 3.81-3.75 (m, 1H), 3.72 (s, 3H), 3.68-
                                                
37 a) Yao, J.; Liu, H.; Zhou, T.; Chen, H.; Miao, Z.; Dong, G.; Wang, S.; Sheng, C. Tetrahedron 2012, 68, 
     3074. b) Wu, W.; Zhang, Z.; Liebeskind, L. S. J. Am. Chem. Soc. 2011, 133, 14256.  
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3.63 (m, 1H), 2.25-2.20 (m, 1H), 2.07-1.94 (m, 4H), 1.42 (s, 9H), 1.03 (d, J=6.8 Hz, 3H), 
0.93(d, J=6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 172.44, 171.16, 155.86, 79.34, 
58.78, 56.80, 52.11, 47.10, 31.32, 29.02, 28.33, 24.99, 19.26, 17.36.   
 
(S)-1-((S)-2-((tert-butoxycarbonyl)amino)-3-methylbutanoyl)pyrrolidine-2-
carboxylic acid (1.36) 
 
To a stirring solution of dipeptide 1.35 (309 mg, 0.940 mmol, 1.0 equiv.) in dry 
THF (19.0 mL) at 0 °C was added 1 M NaOH (2.06 mL, 2.07 mmol, 2.2 equiv.). The 
reaction was warmed up slowly and stirred overnight. The reaction mixture was then 
quenched with 1 M HCl (6 mL), extracted with DCM (3x30 mL), and the combined 
organic layers dried over Na2SO4, filtered and concentrated. The crude product was 
thoroughly rinsed with diethyl ether to give 273 mg (93%) of 1.36 as a white solid 
consistent with known spectroscopic data.38 (mp 140-142 °C). 1H NMR (500 MHz, 
CDCl3): δ 5.14 (d, J=7.8 Hz, 1H), 4.64 (m, 1H), 4.28 (dd, J=9.3, 6.8 Hz, 1H), 3.83-3.79 
(m, 1H), 3.65-3.62 (m, 1H), 2.40 (m, 1H), 2.08-1.97 (m, 4H), 1.44 (s, 9H), 0.99 (d, J=6.8 
Hz, 3H), 0.`95(d, J=6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 173.76, 173.05, 156.03, 
80.07, 59.79, 57.18, 47.99, 31.52, 28.54, 27.86, 25.13, 19.47, 17.75.  
                                                
38 a) Boruah, A.; Rao, I. N.; Nandy, J. P.; Kumar, S. K.; Kunwar, A. C.; Igbal, J. J. Org. Chem. 2003, 68, 
    5006. b) Ganellin, C. R.; Bishop, P. B.; Bambal, R. B.; Chan, S. M. T.; Leblond, B.; Moore, A. N. J.; 
    Zhao, L.; Bourgeat, P.; Rose, C.; Vargas, F.; Schwartz, J. C. J. Med. Chem. 2005, 48, 7333.   
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(S)-tert-butyl (1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxo-5-(3-
tosylguanidino)pentan-2-yl)carbamate (1.39) 
 
A flame dried 25 mL round bottom flask was charged with Boc-Arg(Tos)-OH 
(1.20 g, 2.85 mmol, 1.0 equiv.), 7-amino-4-methylcoumarin (AMC) (500 mg, 2.85 mmol, 
1.0 equiv.) and dry pyridine (8.60 mL) under N2. The resulting yellow solution was 
cooled to -10 °C and phosphorous oxychloride, which had been freshly distilled from 
itself under reduced pressure (292 µL, 3.41 mmol, 1.1 equiv.), was added dropwise. A 
color change from yellow to neon orange occurred and darkened as the reaction warmed 
to room temperature overnight. The reaction was slowly quenched with H2O (20 mL), 
extracted with DCM (3x40 mL), and washed with 1 M HCl till the aqueous layer reached 
a pH of 2. The combined organic layers were dried with Na2SO4, filtered, and 
concentrated to afford a crude product which was purified by silica gel column 
chromatography (4:1 ethyl acetate:hexanes to 100% ethyl acetate) to give 899 mg (54%) 
of Arg-AMC adduct 1.39 as a white solid. (mp 132-134 °C). 1H NMR (500 MHz, 
CDCl3): δ 9.48 (br, 1H), 7.82 (m, 2H), 7.74 (s, 1H), 7.66 (m, 1H), 7.47 (m, 1H), 7.18 (d, 
J=8.3 Hz, 2H), 6.43 (br, 3H), 6.16 (s, 1H), 5.66 (br, 1H), 4.62 (m, 1H), 3.29 (m, 2H), 
2.39 (s, 6H), 1.94 (m, 1H), 1.69 (m, 3H), 1.43 (s, 9H). DART-HRMS (m/z): Calc’d for 
[M+H]+ (C28H35N5O7S): 586.2330; Found: 586.2336. 
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(S)-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxo-5-(3-tosylguanidino)pentan-
2-aminium 2,2,2-trifluoroacetate (1.40) 
 
 Starting Arg- AMC adduct 1.39 (208 mg, 0.355 mmol, 1.0 equiv.) was combined 
with trifluoroacetic acid (897 µL, 11.7 mmol, 33 equiv.) and DCM (2.50 mL) in a small 
vial under N2. The reaction was stirred for 1.5 hours till TLC analysis (4:1 ethyl 
acetate:hexanes) indicated complete consumption of 1.39. The crude reaction mixture 
was concentrated and triturated with diethyl ether (3x1 mL) to afford TFA salt 1.40 as a 
white solid which was used in the next reaction without further purification.  
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tert-butyl ((S)-3-methyl-1-((R)-2-(((R)-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-
1-oxo-5-(3-tosylguanidino)pentan-2-yl)carbamoyl)pyrrolidin-1-yl)-1-oxobutan-2-
yl)carbamate (1.41) 
 
DIPEA (72.5 µL, 0.417 mmol, 5.0 equiv.) was added slowly to a solution of TFA 
salt 1.40 (50.0 mg, 0.0834 mmol, 1.0 equiv.) in DCM (0.420 mL) under N2. After 15 
minutes of stirring, EDC·HCl (22.4 mg, 0.117 mmol, 1.4 equiv.), HOBt (15.8 mg, 0.117 
mmol, 1.4 equiv.), and Boc-Val-Pro-OH 1.36 (28.8 mg, 0.0917 mmol, 1.1 equiv.) were 
also added to the reaction vial. The vial was capped and the reaction mixture allowed to 
stir overnight.   The reaction was diluted with DCM (1 mL) and quenched with 1 M HCl 
(1 mL). The organic layer was then washed with saturated aqueous sodium bicarbonate (1 
mL), dried over Na2SO4, filtered, and concentrated. The resulting light yellow solid was 
purified by silica gel column chromatography (10:1 ethyl acetate:hexanes) to give 42 mg 
(64%) of 1.41 as a white solid. 1H NMR (500 MHz, CDCl3): δ 9.48 (br, 1H), 7.76-7.71 
(m, 4H), 7.54-7.45 (m, 2H), 7.2 (d, J=8.3 Hz, 2H), 6.45 (br, 2H), 6.15 (s, 1H), 5.26 (br, 
1H), 4.69-4.53 (m, 2H), 4.25-4.22 (m, 1H), 3.80- 3.63 (m, 2H), 3.35-3.24 (m, 2H), 2.37 
(s, 6H), 2.20 (m, 1H), 2.12-1.93 (m, 4H), 1.75-1.53 (m, 4H), 1.40 (s, 9H), 0.91 (dd, 
J=36.6, 5.9 Hz, 6H). 13C NMR (125 MHz, CDCl3): δ 172.66, 172.43, 171.24, 161.44, 
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157.34, 156.04, 154.15, 152.73, 142.46, 141.73, 140.64, 129.53, 126.15, 125.20, 116.19, 
113.40, 107.69, 79.91, 60.81, 57.53, 54.2, 48.15, 40.40, 31.28, 29.88, 29.52, 28.54, 26.13, 
25.35, 21.62, 19.54, 18.73, 17.90. IR (KBr thin film): 3430 (br), 3325 (br), 2970 (m), 
2928 (m), 1703 (m), 1620 (s), 1582 (m), 1530 (m), 1445 (w), 1391 (m), 1367 (w), 1167 
(m), 916 (m), 588 (m). DART-HRMS (m/z): Calc’d for [M+Na]+ (C38H51N7O9S): 
804.3361; Found: 804.3369. 
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Chapter 2: Synthetic Studies Towards the Total Synthesis of Torilin 
 
2.1 Introduction 
 The guaiane sesquiterpene Torilin (Figure 2.1) was first isolated in 1966 from the 
seeds of Torilis japonica, a Japanese hedge parsley.39 Extracts of Torilis japonica have 
been used in East Asian folk medicine for centuries. This is not surprising, as studies over 
the last twenty years have revealed that Torilin posses a wide range of interesting 
biological activities, including anti-inflammatory activity, anti-cancer activity and anti-
microbial activity.40  
 
Figure 2.1. Structures of the Guaiane Sesquiterpene Skeleton and Torilin 
 
 
Sesquiterpenes are 15 carbon terpenoids derived from the assembly of three 
isoprene units. The structural diversity in this group of compounds is vast and includes 
acyclic, monocyclic, bicyclic, tricyclic and tetracyclic frameworks. All of the different 
sesquiterpene skeletons are biologically produced from a single substrate, farnesyl 
                                                
39 a) Nakazaki, M.; Chikamatsu, H.; Maeda, M. Tetrahedron Lett. 1966, 37, 4499. b) Chikamatsu, H.; 
    Maeda, M.; Nakazaki, M. Tetrahedron 1969, 25, 4751. 
40 For an overview of Torilis japonica extract use in East Asian folk medicine and a detailed review of  
    studies on the biological activities of Torilin see: New Applications of Cyclobutadiene Cycloadditions: 
    Diversity and Target Oriented Synthesis, Marineau, J. J. Ph.D. dissertation, Department of Chemistry, 
    Boston College, 2010. 
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diphosphate, which undergoes enzymatic cyclizations and/or rearrangements to provide 
these diverse carbon frameworks.41 Sesquiterpenes, like Torilin and many terpene natural 
products, possess interesting biological activities including antimicrobial, antitumor and 
cytotoxic activity.42   
One particular subclass of sesquiterpenes are those that contain a fused 5-7 ring 
system. Sesquiterpenes containing this bicyclo[5.3.0]decane or hydroazulene ring system 
can be further subdivided based on the particular substitution pattern on the ring (Figure 
2.2). Torilin, for instance, belongs to the guaiane subgroup of hydroazulene 
sesquiterpenes. Some key strategies and representative examples for the synthesis of this 
important and synthetically challenging fused 5-7 ring system will be reviewed in section 
2.2.43  
 
 
 
 
 
 
 
 
                                                
41 Mann, J.; Davidson, R. S.; Hobbs, J. B.; Banthorpe, D. V.; Harborne, J. B. Natural Products: Their 
   Chemistry and Biological Significance, 1st ed,; Longman: 1994.   
42 a) Modzelewska, A.; Sur, S.; Kumar, S. K.; Khan, S. R. Curr. Med. Chem. Anticancer Agents 2005, 5, 
    477. b) Siyuan, Z.; Yen-Kim, W.; Choon-Nam, O.; Han-Ming, S. Curr. Med. Chem. Anticancer Agents 
    2005, 5, 239. 
43 For a detailed overview of synthetic approaches towards the total syntheses of guaiane sesquiterpenes 
    see: Intramolecular Cycloaddition of Cyclobutadiene: Applications Toward Functionalized 5-7-5  
    Tricyclic Ring Systems and Guaiane Natural Products, He, J. Ph.D. dissertation, Department of 
    Chemistry, Boston College, 2012. 
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Figure 2.2. Sesquiterpenes Possessing the Bicyclo[5.3.0]decane Framework 
 
 
2.2 Background  
 The bicyclo[5.3.0]decane ring system is a common, but synthetically challenging 
carbon framework. A wide variety of strategies have been developed to access this 
important structural motif. These approaches to the fused 5-7 ring system include tactics 
involving: ring-closing metathesis, rearrangement of other ring systems, cycloadditions, 
acid/base mediated cyclizations, and diazocarbonyl chemistry. Some representative total 
syntheses using these strategies will be discussed below.                    
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2.2.1 Ring Closing Metathesis 
In 1996 Grubbs published a report44 that described an ene-yne-ene ring-closing 
metathesis (RCM) reaction that resulted in the formation of the bicyclo[5.3.0]decane ring  
system in a single operation starting from dienyne 2.1 (Scheme 2.1). The positioning of 
the branched acetylene group plays a vital role in this transformation relaying one ring-
closing metathesis to the other. Furthermore, in order to avoid the formation of undesired 
6-6 ring systems, the olefins in starting dienyne 2.1 are differentiated by disubstitution of 
one of these olefins. Since it is known that monosubstituted olefins undergo 
intermolecular acyclic metathesis faster than disubstituted olefins, the regiochemical 
control of this initial metathesis allows for the control of the final bicyclic framework. 
 
Scheme 2.1. Synthesis of Bicyclo[5.3.0]decanes Through Ene-yne-ene Ring Closing 
Metathesis 
 
 
Recently, the Yang group published the synthesis of the tetracyclic core of 
Nanolobatolide (Scheme 2.2), 45 a novel C18 terpenoid-related natural product with anti-
neuroinflammatory and neuroprotective properties. Access to the bicyclo[5.3.0]decane 
                                                
44 Kim, S. H.; Zeurcher, W. J.; Bowden, N. B.; Grubbs, R. H. J. Org. Chem. 1996, 61, 1073. 
45 Chang, L.; Jiang, H.; Fu, J.; Liu, B.; Li, C. C.; Yang, Z. J. Org. Chem. 2012, 77, 3609. 
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portion of this molecule was realized through an ene-yne-ene ring-closing metathesis. 
The Yang group hoped that access to this core structure would allow them not only to 
achieve the total synthesis of Nanolobatolide, but would allow for modular construction 
of a library of analogues for later medicinal chemistry studies. Key intermediate 2.4 was 
generated from commercially available β-citronellene (2.3) in four steps. Treatment of 
dienyne 2.4 with Grubbs’ second generation catalyst in toluene at 60 °C for 48 hours gave 
the desired fused 5-7 ring system in excellent yield. Further transformations, including a 
Eu(fod)3 catalyzed intermolecular Diels-Alder reaction and a biomimetic epoxide 
opening reaction gave the desired tetracycle 2.6 in eight steps from RCM product 2.5.  
Efforts to complete the total synthesis of Nanolobatolide are currently underway in the 
Yang group.  
 
Scheme 2.2. Application of an Ene-yne-ene Ring Closing Metathesis in the Synthesis of 
the Tetracyclic Core of Nanolobatolide 
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2.2.2 Rearrangement of Other Ring Systems  
 An interesting alternative route to the formation of fused 5-7 ring systems is the 
expansion or contraction of pre-existing fused ring systems. One such strategy published 
by Booker-Millburn46 utilizes a tandem free radical ring expansion-cyclization reaction 
sequence to access the desired bicyclo[5.3.0]decane ring system (Scheme 2.3). The 
starting cyclopropyl trimethylsilyl ether 2.7 was treated with 2.2 equivalents of 
anhydrous FeCl3 in dry DMF at 0 °C to give the desired trans fused bicyclic chloro 
ketone 2.9 as a single diastereomer. Optimization of the time of addition of FeCl3 was 
critical in order to avoid formation of β-chloro ketone 2.10, which predominated at higher 
concentrations of ferric chloride, or formation of complicated reaction mixtures if 
addition was too slow.   
 
Scheme 2.3. Synthesis of Bicyclo[5.3.0]decanes Through Free Radical Tandem Ring 
Expansion-Cyclization 
 
 
                                                
46 Booker-Millburn, K.; Thompson, D. F. J. Chem. Soc. Perkin Trans. 1 1995, 2315.  
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The stereochemical outcome of this transformation was confirmed through X-ray 
crystallography of the corresponding sulfone, which was generated from chloro ketone 
2.9 through reaction with the potassium salt of benzenethiol followed by oxidation with 
Oxone®.  The formation of the trans fused ring junction can be explained by considering 
the intermediate carbocyclic radical, which can exist in two possible chair-like 
conformations (Scheme 2.4). In conformation 2.8A the butenyl side chain is axial, which 
is disfavored, whereas in 2.8B the side chain is equatorial and thus leads to the expected 
and observed stereochemical outcome. 
 
Scheme 2.4 Stereochemical Outcome of the Free Radical Tandem Ring Expansion-
Cyclization 
 
 
 In 2003, the Booker-Milburn group applied this methodology to protecting group 
free total syntheses of (±)-Pogostol and (±)-Kessane (Scheme 2.5).47 Pogostol, isolated 
from the oil of the patchouli plant, has been shown to possess anti-nausea and anti-
vomiting properties and has been traditionally used in Chinese medicine. Kessane, whose 
structure can be related to Pogostol through a cyclization, was isolated in 1967 from the 
Valeriana offcinalis plant.  To synthesize the key intermediate cyclopropyl TMS ether 
                                                
47 Booker-Millburn, K.; Jenkins, H.; Charmant, J. P. H.; Mohr, P. Org. Lett. 2003, 5, 3309. 
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2.13, enone 2.12 was subjected to a conjugate addition with 3-butenylmagnesium 
bromide, followed by in situ trapping of the intermediate enolate with TMSCl, and 
Simmons Smith cyclopropanation of the resulting TMS enol ether. Transformation of 
cycloproyl TMS ether 2.13 into bicyclo[5.3.0]decane 2.14 was accomplished through the 
tandem ring expansion-cyclization strategy mediated by Fe(III).  Addition of 1,4-
cyclohexadiene provided the necessary hydrogen atom source in this transformation. 
Ketone 2.14 was transformed into (±)-Pogostol and (±)-Kessane in three and five steps, 
respectively.  
 
Scheme 2.5. Application of the Free Radical Tandem Ring Expansion-Cyclization 
Strategy in the Total Syntheses of (±)-Pogostol and (±)-Kessane 
 
 Another rearrangement strategy was reported by the White group. 48  They 
accomplished the formation of hydroazulenes through a Bu3SnH/AIBN or SmI2/ROH 
                                                
48 Colclough, D.; White, J. B.; Smith, W. B.; Chu, Y. J. Org. Chem. 1993, 58, 6303.   
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mediated transannular cyclization of trans or cis cyclodec-5-enone (Scheme 2.6).  The 
transformation of (E)-cyclodec-5-enone (2.15) was slightly sluggish, but completely 
clean with no ketone reduction product observed under either reaction conditions. 
Elimination of the alcohol from the SmI2 mediated cyclization of ketone 2.15 led to 
formation of cis-bicyclo[5.3.0]dec-5-en-1-ol and other unidentified products. The (Z)-
cyclodec-5-enone (2.16) was much less reactive than its trans counterpart, and required 
the addition of HMPA to the SmI2 mediated reaction. Interestingly, both olefin isomers 
underwent cyclization to give the same cis-fused ring product 2.17.  
 
Scheme 2.6. Synthesis of Bicyclo[5.3.0]decanes Through a Free Radical Transannular 
Cyclization of Cyclodec-5-enone 
 
  
 In 1993 White’s group applied their transannular cyclization methodology to the 
total syntheses of (±)-Africanol and (±)-Isoafricanol (Scheme 2.7).49  The syntheses of 
these two africane sesquiterpenes began with the transformation of cyclohexenone 2.18, 
into two 5-cyclodecenone diastereomers 2.20 and 2.23 in four steps. The last 
                                                
49 Fan. W.; White, J. B. J. Org. Chem. 1993, 58, 3557. 
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transformation in this four step sequence, an anionic oxy-Cope rearrangement, generated 
the unstable 5-cyclodecenones which were subjected to the transannular cyclization 
without purification. Na/C10H8 or n-Bu4NF mediated cyclization yielded the desired cis 
fused 5-7 ring systems 2.21 and 2.24, respectively. Finally, hydroazulenols 2.21 and 2.24 
were cleanly cyclopropanated on the less hindered convex face to give (±)-Africanol in 
11% overall yield and (±)-Isoafricanol in 15% overall yield.      
 
Scheme 2.7. Application of the Transannular Cyclization to the Total Syntheses of (±)-
Africanol and (±)-Isoafricanol 
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2.2.3 Cycloadditions 
 In principle, a number of different cycloaddition processes result in the formation 
of 5-7 fused ring systems: [4+3] cycloadditions, [5+2] cycloadditions, and [6+1] 
cycloadditions. These cycloaddition processes can be promoted by heat, light, Lewis 
acids, high pressure, sonication, or transition metal catalysts. An example of an acid 
promoted [4+3] cycloaddition and a transition metal catalyzed [5+2] cycloaddition will 
be discussed here.  
  The [4+3] cycloaddition involves the reaction of an allylic cation and a diene to 
produce a seven member ring. The first example of [4+3] cycloaddition of acyclic 
precursors to generate hydroazulenes was published by the Giguere group in 1988, and an 
improvement to the same methodology was later published in 1990.50 The intramolecular 
Hoffmann-Noyori reaction of Z,E-trienol 2.25, initiated by ionization with triflic 
anhydride, generated the desired [4+3] cycloaddition product 2.27 (Scheme 2.8) in 82% 
yield and excellent diastereoselectivity (92% of cis-exo product). The geometry of the 
olefin played a key role in this transformation; the E,E-trienol stereoisomer produced a 5-
5 fused ring system through a [3+2] cycloaddition.   
 
 
 
 
 
                                                
50 a) Giguere, R. J.; Duncan, S. M.; Bean, J. M.; Purvis, L. Tetrahedron Lett. 1988, 29, 6071. b) Giguere,             
R.J.; Tassely, S. M.; Rose, M. I. Tetrahedron Lett. 1990, 31, 4577.  
77
  
Scheme 2.8. Synthesis of Bicyclo[5.3.0]decanes Through an Intramolecular Hoffman-
Noyori Reaction 
 
 
 The total synthesis of (±)-Aphanamol (Scheme 2.9), the first total synthesis to 
utilize this intramolecular [4+3] cycloaddition methodology, was reported by the 
Harmata group in 1997.51 Aphanamol, an isodaucane sesquiterpene, was first isolated 
from the fruit peel of the Indonesian tree Aphanamixis grandifolia in 1984. Harmata’s 
total synthesis began with aldehyde 2.28, which was transformed into allylic alcohol 2.29 
in four steps. The key intramolecular Hoffman-Noyori [4+3] cycloaddition with triflic 
anhydride produced the desired hydroazulene 2.30 as a single cycloadduct albeit in low 
yield. Interestingly, although cycloaddition precursor 2.29 was a 1:1 mixture of 
stereoisomers, no [3+2] adducts were detected. Furthermore, while the yield of this key 
step was low, the reaction was clean, and no polymerization issues were observed.  MOM 
deprotection of 2.30 yielded racemic Aphanamol in 5% overall yield. Despite the low 
yield in the key transformation, this total synthesis is still notable because it was the first 
to utilize this [4+3] cycloaddition strategy to construct the bicyclo[5.3.0]decane carbon 
framework.     
 
                                                
51 Harmata, M.; Carter, K. W. Tetrahedron Lett. 1997, 38, 7985.  
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Scheme 2.9. Application of an Intramolecular Hoffmann-Noyori Reaction in the Total 
Synthesis of (±)-Aphanamol 
 
 Wender’s group was the first to describe the formation of 5-7 fused ring systems 
through a transition metal catalyzed [5+2] cycloaddition of vinylcyclopropanes with 
alkynes,52 and they later expanded this methodology to include alkene dienophiles53 
(Scheme 2.10). It is believed that this transformation proceeds through the formation of 
metallacyclopentene intermediate 2.34, which undergoes a ring expansion driven by the 
ring strain of the attached cyclopropane ring to form metallacyclooctadiene 2.35. 
Reductive elimination of 2.35 provides the desired seven membered ring system (Scheme 
2.10). This transformation has been shown to work with a wide range of alkynes 
including terminal, internal, electron rich, electron poor and conjugated alkyne systems. 
A wide variety of alkene substrates were also well tolerated in this reaction with 
exclusively cis-fused 5-7 ring system formation. Terminally substituted alkenes, however, 
                                                
52 a) Wender, P. A.; Takahashi, H.; Witulski, B. J. J. Am. Chem. Soc. 1995, 117, 4720. b) Wender, P.A.;    
    Sperandio, D. J. J. Org. Chem. 1998, 63, 4164. 
53 a) Wender, P. A.; Husfeld, C. O.; Langkopf, E.; Love, J. A. J. Am. Chem. Soc. 1998, 120, 1940.  
    b) Wender, P. A.; Husfeld, C. O.; Langkopf, E.; Love, J. A.; Pleuss, N. Tetrahedron 1998, 54, 7203. 
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did prove to be problematic resulting in the formation of complex mixtures. Addition of 
silver triflate to the reaction mixture was found to facilitate the reaction, likely by 
precipitation of silver chloride to open a coordination site on the rhodium. Certain 
challenging alkyne substrates performed better when the more reactive [Rh(CO)2Cl]2 was 
used. However, this catalyst did not give any desired bicyclo[5.3.0]decane product when 
terminal alkynes or alkene vinylcyclopropanes were reacted. Finally, the use of chiral 
catalysts to render this process enantioselective was also examined by Wender.52b 
 
Scheme 2.10.  Synthesis of Bicyclo[5.3.0]decanes Through a Transition Metal Catalyzed 
[5+2] Cycloaddition 
 
 
 Subsequently, Wender reported the expansion of this methodology to include 
allene-vinylcyclopropanes (Scheme 2.11A). 54  Interestingly, the RhCl(PPh3)3 catalyzed 
cycloadditions of monosubstituted allene 2.37 (R1, R2=H) and terminally disubstituted 
                                                
54 Wender, P. A.; Glorius, F.; Husfeld, C. O.; Langkopf, E.; Love, J. A. J. Am. Chem. Soc. 1999, 121, 5348.  
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allene 2.37 (R1, R2=Me) gave a mixture of cis and trans fused cycloadducts. Changing 
the catalyst to [Rh(CO)2Cl]2 greatly improved the cis-fused selectivity of this reaction. 
Chirality transfer with chiral allene 2.39 (Scheme 2.11B) was also tested and resulted in 
complete retention of stereochemistry.  
 
Scheme 2.11. Rh(I) Catalyzed Allene-Vinylcyclopropane [5+2] Cycloaddition 
 
 
The utility of these Rh-catalyzed [5+2] cycloadditions was demonstrated through 
the enantioselective total synthesis of (+)-Dictamnol, a trinorguaiane sesquiterpene 
isolated from the roots of Dictamnus dascarpus TURCZ (Scheme 2.12). 55 
Enantiomerically enriched key interemediate 2.42 was prepared in 3 steps from 
commercially available cyclopropanecarboxyaldehyde (2.41). It was predicted that the 
absolute stereochemistry of C-8 in 2.42 could be used to control the stereochemistry at 
                                                
55 Wender, P. A.; Fuji, M.; Husfeld, C. O.; Love, J. A. Org. Lett. 1999, 1, 137. 
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the ring fusion in the subsequent cycloaddition. Indeed, Rh(I) catalyzed cycloaddition of 
2.42 afforded cycloadduct 2.43 in 76% yield and 9:1 diastereoselectivity favoring the 
desired C-8 epimer. Oxidation of hydroazulene 2.43, silica gel epimerization to the trans-
fused ketone, and subsequent methylmagnesium bromide addition gave a 1:1 mixture of 
Dictamnol and epi-Dictamnol. After separation of the two epimers, the desired natural 
product was isolated in 9% overall yield.  
 
Scheme 2.12. Application of a Transition Metal Catalyzed [5+2] Cycloaddition 
in the Asymmetric Total Synthesis of (+)-Dictamnol 
 
 
2.2.4 Acid/Base Mediated Cyclizations 
 The utility of acid or base mediated intramolecular aldol condensation in the 
formation of the bicyclo[5.3.0]decane framework is well documented in the literature.56 
                                                
56 For a few examples see: a) Hutchinson, J. H.; Money, T.; Piper, S. E. Can. J. Chem. 1986, 64, 1404. b) 
    Marcos, S.; Oliva, M.; Moro, F.; Diez, D.; Urones, G. Tetrahedron 1994, 50, 12655. c) Chiu, P.; Chen, 
    B.; Cheng, K. F.; Tetrahedron Lett. 1998, 39, 9229.   
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In 1995, 57  the Shea group pioneered a new ‘bridged to fused ring interchange’ 
methodology, involving an intramolecular aldol condensation as the final step (Scheme 
2.13). Trienes 2.44 and 2.45 could be converted to bicyclo[4.3.1]decanes 2.46 and 2.47 
via a type II Diels-Alder reaction, followed by reduction and TBS protection of the 
resulting alcohol. Ozonolysis of bicycles 2.46 and 2.47 gave dicarbonyls 2.48 and 2.49 in 
good yield. Finally, base or acid catalyzed aldol condensation gave the desired 
bicyclo[5.3.0]decanes 2.50 and 2.51 in excellent yield. An attractive feature of this 
methodology is that it allows one to set stereochemistry in the medium sized ring, 
something that is otherwise difficult due to the ring’s conformational flexibility. This can 
be accomplished by setting the stereochemistry in the rigid bicyclic precursor 2.46 or 
2.47, prior to oxidative cleavage. Indeed, reduction of the ketone intermediates that led to 
compounds 2.46 and 2.47 resulted in >95:5 and 30:1 diastereoselectivity, respectively.  
 
Scheme 2.13. Synthesis of Bicyclo[5.3.0]decanes Using a ‘Bridged to Fused Ring 
Interchange’ Methodology 
 
                                                
57 Gwaltney, S. L.; Sakata, S. T.; Shea, K. J. Tetrahedron Lett. 1995, 36, 7177.   
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 With this new efficient methodology in hand, the Shea group reported the total 
syntheses of (±)-Ledol and (±)-Ledene, the following year.58 The synthesis of these two 
aromadendrane sesquiterpenes begins with triene 2.45 (Scheme 2.14). Diethyl aluminum 
chloride mediated Type II Diels-Alder reaction of 2.45 yielded bicyclic ketone 2.52, 
whose stereoselective alkylation and protection of the resulting alcohol gave 
bicyclo[4.3.1]decane 2.53 in excellent yield. Ozonolysis followed by base catalyzed 
intramolecular aldol condensation completed the bridged to fused ring interchange to 
give enone 2.55 in two steps. Elaboration of enone 2.55 to the natural product Ledol was 
accomplished in 4 steps. Finally, dehydration of Ledol gave Ledene in a modest 43% 
yield. This dehydration step could also be accomplished using tert-butyldimethylsilyl 
triflate and potassium hydride. In this case, elimination occurred to give the desired 
product in 59% yield along with 22% of recovered starting material.  
 
 
 
 
 
 
 
 
 
                                                
58 Gwaltney, S. L.; Sakata, S. T.; Shea, K. J. J. Org. Chem. 1996, 61, 7438.  
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Scheme 2.14. Application of the Bridged to Fused Ring Interchange Methodology in the 
Total Syntheses of (±)-Ledol and (±)-Ledene 
 
 
2.2.5 Diazocarbonyl Chemistry  
 The chemistry of diazocarbonyl compounds offers a versatile route to carbon-
carbon bond forming reactions. Davies has shown that tandem cyclopropanation/Cope 
Rearrangement of diazocarbonyl compounds is an attractive strategy for the formation of 
fused 5-7 ring systems (Table 2.1).59 The hydroazulene system may be synthesized 
staring from cyclic vinyldiazomethane 2.56, which in the presence of rhodium(II) catalyst 
undergoes rapid decomposition to generate a rhodium stabilized vinylcarbenoid that is 
then trapped with diene 2.57. The resulting cis-divinylcyclopropane undergoes a facile 
Cope rearrangement to give hydroazulene 2.58. The selective formation of the cis-
                                                
59 Cantrell, W. R.; Davies, H. M. L. J. Org. Chem. 1991, 56, 723.  
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divinylcyclopropane is critical, as the trans stereoisomer cannot achieve the proper 
conformation for facile Cope rearrangement (Table 2.1, Entry A). The cis selectivity of 
the cyclopropanation step can be increased by using oxygenated alkenes (Entries B-G). 
Furthermore, the presence of steric hindrance in the divinylcyclopropane intermediate 
inhibits the Cope rearrangement. In entry B, reaction with trans-1-acetoxy-1,3-butadiene 
gave the expected hydroazulene 2.58 cleanly; however, as entry C shows, upon reaction 
with cis-1-acetoxy-1,3-butadiene the cis-divinylcyclopropane was isolated in 80% yield 
and heating to 220 °C was required to induce Cope rearrangement due to the sterically 
congested transition state of this particular substrate. Subsequently, asymmetric variants 
of this transformation were also explored by the Davies Group.60 
 
Table 2.1. Synthesis of Bicyclo[5.3.0]decanes via an Intermolecular 
Cyclopropanation/Cope Rearrangement 
 
Entry R1 R2 R3 R4 Yield (%) 
A Me Me H H 41a 
B H H OAc H 67 
C H H H OAc 62b 
D H H OTMS H 86 
E OTMS H H H 53 
F OTBDMS H H H 94 
G OTMS H OMe H 59 
  a 20% of the trans-divinylcyclopropane was also formed. b Overall 
                                 yield for cyclopropanation followed by heating at 220 °C. 
                                                
60 a) Davies, H. M. L.; Huby, N. J. S.; Cantrell, W. R.; Olive, J. L. J. Am. Chem. Soc. 1993, 115, 9468. b) 
    Davies, H. M. L.; Doan, B. D. Tetrahedron Lett. 1996, 37, 3967.  
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 The application of this methodology to the total syntheses of (±)-Tremulenolide A 
and (±)-Tremulenediol A (Scheme 2.15) was reported by the Davies group in 1998.61 
Tremulenolide A and Tremulenediol A are two examples of tremulanes, a group of 
sesquiterpene metabolites isolated from the fungus Phellinus tremulae, a wood rotting 
pathogen of the quaking aspen. Starting vinyldiazoacatate 2.60 was prepared in three 
steps from ketone 2.59. The key step, rhodium (II) catalyzed decomposition of 2.60 in the 
presence of diene 2.61, gave a mixture of the desired hydroazulene 2.63 and cis-
divinylcyclopropane 2.62. The crowded boat transition state required for the 
transformation of 2.62 to hydroazulene 2.63 resulted in the lack of conversion; however, 
heating 2.62 to 140 °C gave the hydroazulene 2.63 in 49% yield.  The relative 
stereochemistry at the three newly formed stereocenters in 2.63 was completely 
controlled by the required boat transition state in the Cope rearrangement of 
divinylcyclopropane intermediate 2.62. The selective hydrogenation of the cis olefin in 
2.63 was accomplished by Wilkinson’s catalyst. Hydrolysis of the acetyl group of 2.64 
followed by lactonization resulted in the formation of (±)-Tremulenolide A. Alternatively, 
DIBAL-H reduction of the two ester functionalities in 2.64 resulted in the formation of 
(±)-Tremulenediol A. 
 
 
 
 
 
                                                
61 Davies, H. M. L.; Doan, B. D. J. Org. Chem. 1998, 63, 657. 
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Scheme 2.15. Application of the Intermolecular Cyclopropanation/Cope Rearrangement 
Strategy in the Total Syntheses of (±)-Tremulenolide A and (±)-Tremulenediol 
 
 
2.2.6 Background Summary 
 Bicyclo[5.3.0.]decane sesquiterpenes represent a diverse class of terpene natural 
products. An abundance of different methodologies have been developed that allow us to 
access the synthetically challenging 5-7 fused ring system core of these terpenoids. A 
brief overview of some of these methodologies and their applications in the total 
syntheses of a number of bicyclo[5.3.0.]decane sesquiterpenes was described above.   
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2.3 Synthetic Plan  
 Torilin (Figure 2.1), a synthetically challenging target, contains a highly 
oxygenated hydroazulene core and four stereogenic centers that are all congested around 
the seven membered ring. Consequently, although one approach to Torilin has been 
reported in the literature,62 no complete synthesis has been published so far. However, the 
lack of a synthetic route towards Torilin, is only one of the reason we chose to pursue a 
total synthesis of this natural product. Due to Torilin’s wide range of interesting 
biological activities, we wanted to develop a flexible route to Torilin and structurally 
related compounds for future biological studies. Furthermore, in synthesizing a 
challenging molecule such as Torilin we hoped to further demonstrate the utility of a 
synthetic methodology for medium ring systems developed in the Snapper laboratory.          
 
Scheme 2.16. A Cyclopropanation/Thermal Fragmentation Strategy for the Synthesis of 
Bicyclo[5.3.0]decanes 
 
 
                                                
62 Van den Heuvul, A. K. Scope and Limitation of the Non-aldol Aldol Reaction and Progress Toward the 
    Total Synthesis of Torilin. Ph. D. Dissertation, University of California, Los Angeles, CA, 2004.  
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 Methodology previously developed in the Snapper laboratory allows for rapid 
access to the bicyclo[5.3.0]decane carbon framework of  guaiane sesquiterpenes (Scheme 
2.16).63 Cyclopropanation of the cyclobutadiene cycloadduct 2.67, which is formed from 
the intramolecular cycloaddition of free cyclobutadiene intermediate 2.66, results in the 
formation of tetracycle 2.68. Thermal fragmentation of this highly strained polycyclic 
framework gives the desired fused 5-7 ring system. One key feature of this 
cyclopropanation/fragmentation strategy is the stereochemical inversion that occurs at C1 
in the fragmentation step. This methodology, which allows for the rapid synthesis of 
fused 5-7 ring systems, has been utilized by several former Snapper group members in 
order to synthesize a number of interesting guaiane sesquiterpene natural products 
(Scheme 2.17).64   
 
 
 
 
 
 
 
                                                
63 a) Deak, H. L.; Stokes, S. S.; Snapper, M. L. J. Am. Chem. Soc. 2001, 123, 5152. b) Deak, H. L. 
    Cyclopropanation/Isomerization Strategies Toward the Synthesis of bicyclo[5.3.0]decanes (5-7 ring  
    systems) and Applications in Total Synthesis. Ph.D. Dissertation, Boston College, Chestnut Hill, MA, 
    2004. c) Williams, M. J.; Deak, H. L.; Snapper, M. L. J. Am. Chem. Soc. 2007, 129, 486. d) 
    Williams, M. J. The Development of New Methods Toward Guaiane Natural Products. Ph.D. 
    Dissertation, Boston College, Chestnut Hill, MA, 2007. 
64 a) Leyhane, A. J. Cyclobutadiene Cycloadditions: Applications toward the Synthesis of Functionalized 
    Oxepines and Guaiane Natural Products. Ph.D. Dissertation, Boston College, Chestnut Hill, MA, 2008. 
    b) For a first generation, shorter total synthesis of (+)-Pleocarpenene and (-)-Pleocarpenone see ref. 63c,d.  
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Scheme 2.17. Application of the Cyclopropanation/Thermal Fragmentation Strategy in 
the Total Syntheses of Several Guaiane Sesquiterpene Natural Products 
 
 
Complimentary to the thermal fragmentation strategy, which results in inversion 
of stereochemistry at the C1 position, our group has developed a mild Lewis acid 
mediated fragmentation that allows access to fused 5-7 ring systems with retention of 
stereochemistry at C1 (Scheme 2.18).65 Key tetracycle 2.73 can be synthesized, as before, 
through intramolecular cycloaddition of a free cyclobutadiene intermediate such as 2.66 
followed by cyclopropanation of the resulting cyclobutene. Oxidation of the secondary 
                                                
65 a) Deak, H. L.; Williams, M. J.; Snapper, M. L. Org. Lett. 2005, 7, 5785. b) For a mechanistic rational of  
     the stereochemical outcome of the thermal and Lewis Acid mediated rearrangements see: ref 40 & 43.  
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alcohol in 2.73, followed by Lewis acid mediated rearrangement gives various fused 5-7 
ring systems in good yields. We envisioned that this Lewis acid mediated fragmentation 
could be used to access the hydroazulene core of Torilin with the necessary 
stereochemistry at C1. Thus, we set out to design a synthetic plan which utilized the 
Lewis acid mediated fragmentation as a key step.  
 
Scheme 2.18. A Lewis Acid Mediated Fragmentation Strategy for the Synthesis of 
Bicyclo[5.3.0]decanes 
 
   
 The retrosynthetic analysis of Torilin led us to develop the plan summarized in 
Scheme 2.19. We predicted that Torilin could be generated through a selective 
esterification and acylation of Torilolone. In turn, the secondary alcohol in Torilolone 
could be installed through directed hydroboration oxidation of the precursor olefin, where 
the stereo- and regioselectivity could be controlled by the tertiary hydroxide that is 
already present. Tetrasubstituted enone 2.75 could be generated through a reduction, 
alkylation, and deprotection of α -keto acetal 2.76. The formation of the fused 5-7 ring 
system present in acetal 2.76 represents the key step in our synthesis. Oxidation of highly 
functionalized cyclopropane 2.77 followed by Lewis acid mediated fragmentation would 
afford desired hydroazulene 2.76. The installation of the cyclopropane moiety present in 
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2.77 could be achieved through a diastereoselective cyclopropanation of the precursor 
cyclobutene 2.78. This cyclobutene would be generated through an intramolecular 
cycloaddition of free cyclobutadiene, which is liberated upon oxidation of iron 
cyclobutadiene complex 2.79. Finally, iron complex 2.79 could be synthesized through 
an umpolung addition of the anion of crotyl dithiane 2.80 into known iron aldehyde 2.81.      
   
Scheme 2.19. Retrosynthetic Analysis of Torilin 
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2.4 Synthetic Studies  
 
2.4.1 Umpolung Addition 
 With an auspicious synthetic strategy in hand, we began by preparing 
cyclobutadiene iron aldehyde 2.81 and crotyl dithiane 2.80. The synthesis of aldehyde 
2.81 was accomplished in four steps starting with commercially available α-pyrone (2.82) 
(Scheme 2.20). A photochemically induced 4π electrocyclization, followed by 
coordination of the resulting cyclobutene with diiron nonacarbonyl and concomitant 
decarboxylation yielded cyclobutadiene iron methyl ester 2.83 in 48% yield over two 
steps. DIBAL-H reduction of ester 2.83 followed by MnO2 oxidation of the resulting 
alcohol gave desired cyclobutadiene iron aldehyde 2.81 on a multi gram scale. 
 
Scheme 2.20. Synthesis of Iron Cyclobutadiene Aldehyde 2.81 
 
 
 Synthesis of crotyl dithiane 2.80 was accomplished in one step starting from 
commercially available (E)-1-bromo-2-butene (2.85) (Scheme 2.21). Unfortunately, this 
reaction was complicated by the fact that the crotyl bromide used contained 15% 3-
bromo-1-butene resulting in the formation of undesired byproduct 2.86, which proved 
especially difficult to remove by either column chromatography or careful fractional 
distillation.  
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Scheme 2.21. Synthesis of Crotyl Dithiane 2.80 
 
 
In an attempt to eliminate the formation of the undesired dithiane isomer, methods 
to access pure (E)-1-bromo-2-butene (2.85) or a similar, but more reactive electrophile 
were explored (Scheme 2.22). However, this strategy was quickly abandoned due to low 
yields and/or decomposition of the synthesized crotyl electrophiles upon standing for less 
than 24 hours, even at depressed temperatures. Attempts to utilize these electrophiles 
directly after synthesis also proved unsuccessful.  
 
Scheme 2.22. Synthesis of Crotyl Electrophiles 
 
 
Attention was now turned to the umpolung addition of crotyl dithiane and iron 
aldehyde 2.81 (Scheme 2.23). At first, this umpolung addition suffered from low yields 
(<30%), even with careful control of the amount of tert-butyllithium (t-BuLi) added, 
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which proved detrimental for material throughput so early in the synthesis.66 After 
extended and careful study of the reaction conditions it was concluded that premature 
quenching of the crotyl dithiane anion was the cause of low yield. Extensive drying of 
starting materials over P2O5, and careful cannula transfer of the anion into the aldehyde 
solution was necessary in order to acquire a good yield. Quenching of the reaction after 
30 minutes at 0 °C was also critical, as allowing the reaction to warm to room 
temperature or to stir for extended periods of time seemed to cause degradation of the 
product. Byproduct formation from the addition of dithiane 2.86 into the iron aldehyde 
was also observed, but could be removed by column chromatography.  
 
Scheme 2.23. Umpolung Addition 
 
 
2.4.2 Preparation of a Cyclopropanation Precursor  
With the umpolung addition product available in reasonable yield and gram 
quantities, we proceeded forward with the synthesis. Intramolecular cycloaddition of 2.79 
was achieved through in-situ generation of free cyclobutadiene by oxidation with ceric 
ammonium nitrate (CAN)40 (Scheme 2.24). To attain a high yield, careful control of 
reaction time was necessary, as extended reaction time led to oxidation and cleavage of 
                                                
66 Any excess t-BuLi reacted with the carbonyl ligands of iron aldehyde 2.81 resulting in decreased yield 
     and difficult purification.   
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the 1,3-dithiane functionality. The secondary alcohol in cyclobutene 2.78 was then 
acylated to avoid undesired side reactions in subsequent transformations.  
 
Scheme 2.24. Synthesis of Acylated Cyclobutene 2.90 
 
 
Preliminary data on the cyclopropanation of cyclobutenes 2.78 and 2.90 gathered 
by Dr. Marineau40 suggested that the dithiane functionality would need to be removed in 
order for this transformation to be achieved successfully. Not unexpectedly, we found 
that efficient removal of the 1,3-dithiane was difficult. Numerous existing conditions 
were tested (Table 2.2) and most resulted in poor reactivity, decomposition, or 
irreproducible results. Finally, it was found that an efficient and reproducible one pot 
ketal exchange could be achieved using Hg(ClO4)2 (Scheme 2.25). Careful optimization 
of the reaction conditions43 allowed us to access acetal 2.91 in 42-45% yield.    
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Scheme 2.25. A Successful One Pot Ketal Exchange 
 
 
 
Table 2.2. Conditions Screen for a One Pot Ketal Exchange 
 
Conditions Results 
IBX 
Decomposition/ low yield/ no conversion/ 
irreproducible results 
PhI(CO2CF3)2 
DMP 
NaClO2, KHPO4, 2-methylbut-2-ene 
CAN 
MeI 
NBS, AgNO3 
Selectfluor 
Chloramine-T 
HgCl2 
HgO-BF3 
CuCl2, CuO 
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2.4.3 Alternatives to the Protecting Group Exchange  
 Due to the moderate yield obtained from the protecting group exchange an 
alternative pathway, which would eliminate the need for this exchange and deliver the 
desired cyclobutene in good yield, was explored. Several alternative acyl anion 
equivalents were investigated for this purpose. In our first attempt we hoped to synthesize 
protected cyanohydrin 2.93 or 2.95, which could act as an acyl anion equivalent in an 
umpolung addition with iron aldehyde 2.81 (Scheme 2.26). Unfortunately, all our 
attempts to prepare such an umpolung addition partner failed. After a brief literature 
search we realized that ether protected cyanohydrins of formaldehyde will undergo a 
rapid self-condensation reaction upon deprotonation,67 and thus addition of the anion to 
an electrophile like crotyl bromide will fail.   
 
Scheme 2.26. Protected Cyanohydrin Umpolung Addition 
 
 
 Not discouraged, the preparation of a different acyl anion equivalent was 
attempted. In 1978, the Stork group reported that N,N-diethylaminoacetonitrile (2.97) 
could be successfully reacted with alkyl halides and Michael acceptors without self 
                                                
67 Stork, G.; Ozorio, A. A.; Leong, A. Y. W. Tetrahedron Lett. 1978, 52, 5175. 
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condensation.69 With this result in mind we were able to prepare umpolung addition 
partner 2.98 in good yield (Scheme 2.27). However, all attempts to add the anion of 2.98 
to iron aldehyde 2.81 resulted in the formation of amino ketone 2.101 as the only product 
in low yield.   
 
Scheme 2.27. N,N-diethylaminonitrile Umpolung Addition 
 
As an alternative approach for the preparation of a cyclopropanation precursor, 
addition of iron cyclobutadiene anion derived from 2.103 into corresponding aldehyde 
2.104 was envisioned (Scheme 2.28A). First, preparation of parent iron cyclobutadiene 
2.103 was explored (Scheme 2.28B, C). As shown in Scheme 2.28B, synthesis of iron 
cyclobutadiene 2.103 was attempted through intermolecular photocycloaddition of 
acetylene and vinyl carbonate 2.106 followed by treatment with diiron nonacarbonyl.68 
However, all attempts to generate carbonate 2.107 through photochemical irradiation 
failed. An alternative, albeit more expensive, method for the preparation of iron 
                                                
68 Grubbs, R. H. J. Am. Chem. Soc. 1970, 92, 6693.  
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cyclobutadiene 2.103 was then exploited (Scheme 2.28C). Treatment of commercially 
available cis-3,4-dichlorocyclobutene69 with diiron nonacarbonyl gave the desired iron 
cyclobutadiene in moderate  yield.   
 
Scheme 2.28. An Alternative Retrosynthesis of Cyclobutene 2.91 and Synthesis of Parent 
Cyclobutadiene Iron Tricarbonyl 
 
 
With cyclobutadiene 2.103 in hand we turned our attention to the synthesis of the 
necessary aldehyde partner. Initially aldehyde 2.111 was synthesized in two steps from 
commercially available ester 2.109 (Scheme 2.29A). A protecting group exchange to 
install a cyclic acetal was also achieved. However, preliminary attempts to oxidize 
resulting hydroxy acetal 2.113 failed. Nevertheless, further optimization of the aldehyde 
                                                
69 Sigma Aldrich price in 2013: $208.50/ 1 mL. 
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synthesis was not performed due to the fact that addition of the anion of cyclobutadiene 
2.103 into aldehyde 2.111 proved ineffective even at elevated temperatures due to 
substantial steric hindrance (Scheme 2.29B).  
 
Scheme 2.29. Synthesis of Aldehyde Partner and Reaction with Cyclobutadiene Iron 
Tricarbonyl 
 
 
Wanting to move forward with the synthesis, but having found no efficient 
method to bypass the developed protecting group exchange strategy, we decided to bring 
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material forward using the one pot ketal exchange. With a sufficient amount of 
cyclobutene acetal 2.91 in hand, we turned our attention to the next step in our synthesis.  
 
2.4.4 Cyclopropanation and Key Lewis Acid Mediated Fragmentation  
A highly diastereoselective cyclopropanation of cyclobutene 2.91 was achieved 
via Cu(acac)2 catalyzed decomposition of ethyl diazoacetate (Scheme 2.30). Methylation 
of the resulting functionalized cyclopropane 2.115 gave desired diol 2.77 in excellent 
yield. Single crystal X-ray diffraction of the α -isomer of 2.77 70 confirmed the 
diastereoselectivity of the cyclopropanation step.    
 
Scheme 2.30 Synthesis of Diol 2.77 
 
 
With access to functionalized cyclopropane 2.77 achieved we were ready to test 
our Lewis acid mediated fragmentation methodology in the context of this total synthesis. 
                                                
70 This single crystal was obtained by Dr. Jason J. Marineau 
103
  
Unfortunately, the relatively mild PCC/BF3·Et2O conditions that had been previously 
developed for this transformation proved too harsh for this highly functionalized and 
sensitive substrate. After extensive and careful screening it was found that oxidation and 
Lewis acid mediated rearrangement of diol 2.77 could be accomplished using a 
stoichiometric amount of tetrapropylammonium perruthenate (TPAP) followed by 
coordination with RuCl3 (Scheme 2.31). Surprisingly, this fragmentation gave us two 
products: the expected isomer 2.76 and its diastereomer 2.117 in a 9:1 ratio.71  However, 
aside from the formation of minor diastereomer 2.117 the reaction was completely clean. 
Due to the sensitive nature of these two hydroazulenes the mixture of diastereomers was 
carried forward without separation.   
 
Scheme 2.31. Oxidation and Lewis Acid Mediated Fragmentation 
 
 
 
                                                
71 For an extensive overview of the conditions screened for the oxidation and Lewis acid mediated 
    fragmentation of diol 2.77 and a detailed discussion of the unexpected formation of two fragmentation 
    products see: ref 43.  
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2.4.5 Functionalization of the Hydroazulene Core   
With successful preparation of dienone 2.76 through our Lewis acid mediated 
rearrangement, further elaboration through 1,4 reduction, in-situ trapping of the enolate 
with Comins’ reagent,72  and cross coupling with a methyl Grignard reagent73 was 
envisioned to provide acetal 2.119 (Scheme 2.32A).  However, upon attempted 1,4-
reduction of the mixture of enones 2.76 and 2.117 (Scheme 2.32B) with L-selectride, 
only the 1,2-reduction product was isolated in 9% yield over three steps. Other 1,4-
reduction reagents such as Stryker’s reagent and in-situ generated copper hydride 
reagents also failed to give the desired product.43 
 
Scheme 2.32. Synthesis of acetal 2.119 
 
 
                                                
72 Comins, D. L.; Dehghani, A. Tetrahedron Lett. 1992, 33, 6299. 
73 a) Fürstner, A.; Leitner, A. Angew. Chem. Int. Ed. 2002, 41, 609. b) Scheiper, B.; Bonnekessel, M.; 
    Fürstner, A. J. Org. Chem. 2004, 69, 3943.  
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Meanwhile, due to difficulties in 1,4-reduction, a revised route was pursued. After 
some screening, a mild methylation of enone 2.76 was developed (Scheme 2.33). 
Treatment of the crude mixture of hydroazulenes 2.76 and 2.117 with CeCl3-MeLi gave a 
mixture of hydroxyl acetals that were easily separable by column chromatography. 
Through this minimally optimized method, the desired hydroxyl acetal 2.12174 could be 
isolated in 47% yield over 3 steps from diol 2.77.  
 
Scheme 2.33. Synthesis of hydroxyl acetal 2.121 
 
2.4.6 Proposed Completion of Torilin Synthesis  
 To elaborate hydroxyl acetal 2.121 to our target Torilin, reduction and 
deprotection of the acetal would need to be achieved. Preliminary studies on the 
deprotection of acetal 2.12143 showed that removal of the newly installed α -hydroxyl 
would need to be achieved first in order to prevent epimerization and other undesired 
transformations during this deprotection step. A literature search provided us with the 
inspiration to achieve the desired deoxygenation. Scheme 2.34 outlines two potential 
                                                
74 For a discussion on the elaboration of 2.121 to other Torilin related guaiane sesquiterpene natural 
     products see: ref 43.   
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routes to access deoxygenated hydroazulene 2.126 through a reductive 1,3-transportation 
of allylic alcohol.75    
 
Scheme 2.34. Potential Routes for the Synthesis of Hydroazulene 2.126 
 
 
Once access to hydroazulene 2.126 has been achieved we are hopeful that a 
relatively straightforward route to Torilin can be developed (Scheme 2.35). We 
envisioned that installation of the secondary hydroxyl in 2.129 could be achieved in a 
stereo- and regioselective manner through tertiary alcohol76 or corresponding acetate77 
directed hydroboration of the olefin in 2.126.  If inadequate selectivity is achieved in this 
transformation, a two step route may be utilized. Directed epoxidation78 of starting 
hydroazulene 2.126, followed by chelation controlled regioselective reductive epoxide 
                                                
75 For more details see: ref. 43 and references cited therein.  
76 Rarig, R. A.; Scheideman, M.; Vedejs, E. J. Am. Chem. Soc. 2008, 130, 9182. 
77 House, H.; Melillo, D. G. J. Org. Chem. 1973, 38, 1398. 
78 Hoveyda, A. H.; Evans, D. A.; Fu, G. C. Chem. Rev. 1993, 93, 1307. 
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ring opening79 should generate desired diol 2.129. Finally, the synthesis of Torilin may be 
completed through mild deprotection of 2.129, 80  followed by selective Yamaguchi 
esterfication,81 and acylation.82  
 
Scheme 2.35. Proposed Completion of the Synthesis of Torilin  
 
 
 
                                                
79a) Dai, L.-X.; Lou, B.-I.; Zhang, Y.-Z.; Guo, G.-Z. Tetrahedron Lett. 1986, 27, 4343. b) Colombini, M.; 
    Crotti, P.; Di Bussolo, V.; Favero, L.; Gardelli, C.; Macchia, F.; Pineschi, M. Tetrahedron 1995, 51, 
    8089. c) Chini, M.; Crotti, P.; Flippin, L. A.; Macchia, F. J. Org. Chem. 1991, 56, 7043. 
 
80 a) Evans, D. A.; Connell, B. T. J. Am. Chem. Soc. 2002, 125, 10899. b) Gautier, E. C. L.; Graham, A. E.;                                                                              
     McKillop, A.; Standen, S. P.; Taylor, R. J. K. Tetrahedron Lett. 1997, 28, 1881. 
81 Dhimitruka, L.; SantaLucia, Jr. J. Org. Lett. 2006, 8, 47. 
82 a) Procopiou, P. A.; Baugh, S. P. D.; Flack, S. S.; Inglis, G. G. A. J. Org. Chem. 1998, 63, 2342. b) 
     Chakraborti, A. K.; Gulhane, R. Tetrahedron Lett. 2003, 44, 6749. c) Ishihara, K.; Kubota, M.; Kurihara, 
     H.; Yamamoto, H. J. Org. Chem. 1996, 61, 4560. 
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2.5 Conclusion 
 This chapter described our efforts towards the total synthesis of Torilin, a natural 
product with a number of important biological activities. The key step in this synthesis 
was designed to test the Lewis acid mediated fragmentation strategy developed in the 
Snapper laboratory in the context of a complicated natural product synthesis. We were 
able to successfully achieve the synthesis of a highly functionalized cyclopropane 
interemediate as a precursor for the key oxidation and Lewis acid mediated fragmentation. 
Transformation of this functionalized cyclopropane intermediate into the desired fused  
5-7 ring system has also been realized and has supported the utility of our methodology. 
Efforts to complete the total syntheses of Torilin and related guaiane natural products are 
currently underway.    
 
2.6 Experimental 
 
2.6.1 General Information 
Proton nuclear magnetic resonance spectra (1H-NMR) were measured on a Varian 
Gemini-400 (400 MHz), a Varian Gemini-500 (500 MHz), or a Varian Inova-500 (500 
MHz) spectrometer. Chemical shifts are reported in ppm downfield from 
tetramethylsilane with the solvent resonance as the reference (CDCl3: δ 7.26 ppm). Data 
are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q 
= quartet, br = broad, m = multiplet), coupling constants (Hz), and integration. Carbon 
nuclear magnetic resonance spectra (13C-NMR) were recorded on a Varian Gemini-400 
(100 MHz), or a Varian Gemini-500 (125 MHz) spectrometer with complete proton 
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decoupling. Chemical shifts are reported in ppm downfield from tetramethylsilane with 
the solvent resonance as the reference (CDCl3: δ 77.23 ppm). Infrared (IR) spectra were 
recorded on a Mattson Galaxy series FTIR and are reported in wave numbers (cm-1). 
Bands are characterized as broad (br), strong (s), medium (m), or weak (w). High 
resolution mass spectral analyses (HRMS) were performed by Marek Domin, Mass 
Spectrometry Laboratory, at Boston College. Melting points (mp) were obtained with a 
Melt-Temp and are reported uncorrected. 
Starting materials and reagents were purchased from commercial suppliers and 
used without further purification, unless otherwise specified and except the following: 
anhydrous dichloromethane (DCM), N,N-dimethyl formamide (DMF), hexanes, toluene, 
diethyl ether (Et2O), tetrahydrofuran (THF) and benzene were used from a solvent 
purification system. 83  Hexanes and Et2O were distilled before use in column 
chromatography when necessary. All oxygen- or moisture-sensitive reactions were 
carried out under N2 atmosphere in oven-dried (140 °C, >24 hrs) or flame-dried 
glassware. Air- or moisture-sensitive liquids were transferred by syringe and were 
introduced into the reaction flasks through rubber septa. Degassing refers to a flow of dry 
N2 (g) bubbling through reaction solvent. Unless otherwise stated, reactions were stirred 
with a Teflon covered stir bar. Concentration refers to the removal of solvent using a 
rotary evaporator followed by use of a vacuum pump at approximately 1 torr. Silica gel 
column chromatography refers to flash chromatography84 and was performed using 60 Å 
(230-400 Mesh ASTM) silica gel purchased from Silicycle. Thin layer chromatography 
                                                
83 Panborn, A.B.; Giardello, M.A.; Grubbs, R.H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 12, 
     1518. 
84 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923. 
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was performed on glass back 60 Å (250 um thickness) silica gel plates purchased from 
Silicycle.  
 
2.6.2 Experimental Procedures  
 
Iron, tricarbonyl[methyl (1,2,3,4-η)-1,3-cyclobutadiene-1-carboxylate] (2.83)85 
 
 α-Pyrone (15.0 g, 97.3 mmol, 1.0 equiv.) was dissolved in DCM (4.86 L) in a 5 L 
photochemical reactor with stir bar and degassed with N2 for 30 min.  The stirring 
solution was then irradiated for 24 hrs at room temperature using a Hanovia medium 
pressure 450 W mercury lamp fitted inside the pyrex glass filter of the reactor.  After 1H 
NMR spectroscopy indicated full consumption of the starting material, irradiation was 
terminated and the solution was concentrated to afford an orange oil, which was used 
directly in the next step without further purification.  
 A 1000 mL 3-neck round bottom flask fitted with condenser, mechanical stirrer 
and Schlenk addition flask was flamed dried and purged with N2. Starting                 
methyl 3-oxo-2-oxabicyclo[2.2.0]hex-5-ene-4-carboxylate (15.0 g, 97.3 mmol, 1.0 
equiv.) was added to the round bottom flask and dissolved in benzene (185 mL). Using a 
glove bag, the Schlenk flask was charged with diiron nonacarbonyl (35.4 g, 97.3 mmol, 
                                                
85 All iron containing compounds are light sensitive and thus reactions should be performed in the dark and 
     products stored wrapped in aluminum foil.  
111
  
1.0 equiv.). The Fe2(CO)9 was then transferred to the round bottom flask and chased with 
10.0 mL of benzene. The round bottom flask was submerged in a preheated 55 °C oil 
bath and mechanical stirring was turned on. After 2.5 hrs stirring was terminated and the 
dark green solution was allowed to cool to room temperature. The solution was then 
filtered through an 8.0 cm plug of basic alumina, celite and sand (1:1:1 ratio) and the 
filtrate was concentrated to afford a green residue. This residue was purified by silica gel 
chromatography86 using a gradient (hexanes, 20:1 hexanes:Et2O, 2:1 hexanes:Et2O) to 
afford 13.3 g (55%) of the desired product as a yellow solid consistent with known 
spectroscopic data.87  1H NMR (500 MHz, CDCl3): δ 4.51 (s, 2H), 4.28 (s, 1H), 3.68 (s, 
3H).  
 
Iron, tricarbonyl[(1,2,3,4-η)-1,3-cyclobutadiene-1-carboxaldehyde] (2.81)85 
 
Diethyl ether (106 mL) was added to a flask containing starting iron ester 2.83 
(13.3 g, 53.0 mmol, 1.0 equiv.) and a stir bar under N2. The resulting solution was cooled 
to 0 °C, and neat diisobutylaluminum hydride (20.8 mL, 117 mmol, 2.2 equiv.) was 
added dropwise. The reaction was then allowed to stir at 0 °C for 5 min followed by 1 hr 
at room temperature. After TLC analysis (3:1 hexanes:Et2O) indicated full consumption 
                                                
 
86 A green band corresponding to Fe3(CO)12 was eluted first using hexanes and 20:1 hexanes: Et2O. Once                                                                                                                                                                                              
     the green color had made its way off the column the gradient was increased to 2:1 to elute the desired 
     orange/yellow band.   
87 Limanto, J.; Snapper, M. L. J. Am. Chem. Soc. 2000, 122, 8071. 
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of the starting material, the solution was cooled back down to 0 °C, diluted with Et2O 
(100 mL), and quenched with dropwise addition of saturated aqueous sodium potassium 
tartrate (150 mL). The resulting thick tan colored gel was allowed to stir for 2 hrs until 
the solution became biphasic. The phases were separated and the aqueous layer was 
extracted with Et2O (3x150 mL) and the combined organic layers were dried over MgSO4, 
filtered and concentrated. The resulting crude oil was recrystallized by dissolving it in 
10% Et2O in hexanes (350 mL) and then concentrating the solution in vacuo until only 
~50 mL hexanes remained and a solid yellow precipitate formed. This process was 
repeated once more and the resulting precipitate was filtered and washed with hexanes to 
give 8.20 g (70%) of recrystallized yellow solid. The mother liquor was then 
concentrated and purified by silica gel chromatography (2:1, 1:1 hexanes:Et2O gradient) 
to yield 2.60 g (22% , 92% combined yield) of desired iron, tricarbonyl[(1,2,3,4-η)-1,3-
cyclobutadiene-1-methanol] as a yellow solid consistent with known spectroscopic data.88 
1H NMR (500 MHz, CDCl3): δ 4.15 (s, 2H), 4.12 (s, 1H), 4.00 (d, J = 5.9 Hz, 2H), 1.45 
(t, J = 5.9 Hz, 1H).  
Iron alcohol (1.00 g, 4.50 mmol, 1.0 equiv.), 4 Å molecular sieves (0.30 g, 30 
wt%), and MnO2 (3.90 g, 45.0 mmol, 10 equiv.) were combined in a 100 mL round 
bottom flask with stir bar and dissolved in DCM (9.00 mL). The resulting solution was 
refluxed at 50 °C overnight. After TLC analysis (1:1 hexanes:Et2O) indicated full 
consumption of starting material, the reaction mixture was cooled to room temperature 
and filtered through a plug of celite, eluting with DCM. The yellow filtrate was 
concentrated and purified by silica gel chromatography (3:1, 2:1, 1:1 hexanes:Et2O 
                                                
88 Williams, M. J.; Deak, H. L.; Snapper, M. L. J. Am. Chem. Soc. 2007, 129, 486. 
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gradient) to give 820 mg (83%) of aldehyde 2.81 as an orange solid consistent with 
known spectroscopic data.88 1H NMR (500 MHz, CDCl3): δ 9.21 (s, 1H), 4.66 (s, 2H), 
4.52 (s, 1H).  
 
(E)-2-(but-2-en-1-yl)-1,3-dithiane (2.80) 
 
To a flame dried 2 neck round bottom flask equipped with a stir bar under N2 was 
added 1,3-dithiane (409 mg, 3.40 mmol, 1.0 equiv.) and THF (17.0 mL). The resulting 
solution was cooled to 0 °C and n-BuLi (1.35 M in hexanes, 2.77 mL, 3.74 mmol, 1.1 
equiv.) was added dropwise. After allowing the reaction to stir at 0 °C for 2 hrs, crotyl 
bromide89 (551 mg, 4.08 mmol, 1.2 equiv.) was added and the reaction was allowed to 
stir for another hour. The reaction was quenched by pouring it into 20 mL of ice cold 
water. The aqueous layer was extracted with Et2O (3x30 mL) and the combined organic 
layers were washed with brine (50 mL), dried over MgSO4, filtered, and concentrated to 
afford an orange-brown oil. The crude oil was fractionally distilled under reduced 
pressure to afford 486 mg (82%) of desired crotyl dithiane 2.80 (containing 3% of 
undesired isomer 2.86) as a clear colorless oil consistent with known spectroscopic 
data.40 1H NMR (500 MHz, CDCl3): δ 5.67-5.44 (m, 2H), 4.11-4.04 (m, 1H), 2.92-2.80 
(m, 4H), 2.52-2.42 (m, 2H), 2.14-2.09 (m, 1H), 1.89-1.80 (m, 1H), 1.69-1.64 (m, 3H). 
 
                                                
89 Commercially available technical grade (E)-1-bromo-2-butene contains 15% 3-bromo-1-butene and 13% 
(Z)-1-bromo-2-butene. 
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(E)-(2-(but-2-enyl)-1,3-dithian-2-yl)-hydroxymethylcyclobutadieneiron tricarbonyl 
(2.79)85 
 
Crotyl dithiane 2.80 (4.13 g, 23.7 mmol, 1.4 equiv.), dried over P2O5 for 24 hrs, 
was dissolved in THF (60.0 mL) in a flame dried 3 neck round bottom flask equipped 
with a stir bar under N2. N,N,N’,N’-tetramethylethylenediamine (2.75 g, 23.7 mmol, 1.4 
equiv) was added and the stirring solution was cooled to -78 °C. t-BuLi (1.05 M, 22.6 mL, 
23.7 mmol, 1.4 equiv.) was then added dropwise over 30 minutes and the reaction was 
allowed to stir at -78 °C for 15 minutes, followed by 2 hrs at 0 °C. At this point, iron 
aldehyde 2.81 (3.72 g, 16.9 mmol, 1.0 equiv.), dried for 24 hrs over P2O5, was dissolved 
in THF (103 mL) in a separate flame dried round bottom flask equipped with a stir bar 
under N2 and cooled to -78 °C. Then, the 0 °C dark orange/wine red solution of dithianyl 
anion was slowly cannula transferred into the orange iron aldehyde solution at -78 °C and 
chased with THF (10.0 mL).90 The reaction was allowed to stir at -78 °C for 30 minutes 
followed by 30 minutes at 0 °C. At this point the reaction was quenched by the addition 
of 1 M HCl (50 mL) and the resulting reaction mixture was transferred into an additional 
50 mL of 1 M HCl and stirred for 45 minutes. The layers were then separated and the 
aqueous layer was extracted with Et2O (3x50 mL). The combined organic layers were 
                                                
90 To ensure the dithianyl anion was transferred unquenched it was critical to dry the cannula thoroughly in 
    the oven prior to use and remove any moisture that condensed on the cannula during transfer with a 
    paper towel.  
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washed with brine (100 mL), dried over MgSO4, filtered, and concentrated to afford a 
dark orange oil. This crude oil was purified by silica gel chromatography91 (hexanes, 2%, 
4%, 10% methyl t-butyl ether in hexanes gradient) to give 3.97 g (60%) of desired 
product 2.79 as a yellow solid consistent with known spectroscopic data.40 1H NMR (500 
MHz, CDCl3): δ 5.69-5.55 (m, 2H), 4.37 (dd, J = 15.4, 1.5 Hz, 1H), 4.30-4.21 (m, 2H), 
4.12-4.11 (m, 1H), 2.96-2.89 (m, 2H), 2.78 (dd, J = 25.4, 1.7 Hz, 1H), 2.69-2.58 (m, 4H), 
2.53-2.49 (m, 1H), 2.08-2.03 (m, 1H), 1.88-1.80 (m, 1H), 1.72-1.66 (m, 3H).    
 
 (±)-(4'S,5'S,6'S)-5'-methylspiro[[1,3]dithiane-2,8'-tricyclo[4.3.0.01,4]non[2]en]-9'-ol 
(2.78)85 
 
 Iron complex 2.79 (989 mg, 2.51 mmol, 1.0 equiv.) was dissolved in acetone 
(1.25 L) in a 2 L erlenmeyer flask with stir bar. Ceric ammonium nitrate (4.13 g, 7.53 
mmol, 3.0 equiv.) was added in one portion to the vigorously stirring solution at room 
temperature. After 10 minutes, the reaction was quenched with saturated aqueous sodium 
bicarbonate (20 mL), allowed to stir for another 10 minutes, and then allowed to settle. 
The solution was filtered to remove undesired cerium salts and the filtrate was 
concentrated till only the aqueous layer remained. This aqueous layer was extracted with 
                                                
91 The crude material was dry loaded onto the column in order to insure full separation from residual crotyl 
    dithiane.  
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Et2O (3x50 mL) and the combined organic layers were dried over MgSO4, filtered, and 
concentrated. The crude product was purified by silica gel chromatography (hexanes, 
30% Et2O in hexanes gradient) to yield 466 mg (73%) of desired cyclobutene 2.78 as a 
yellow oil consistent with known spectroscopic data.40 1H NMR (500 MHz, CDCl3) (2:1 
diastereomeric mixture): δ 6.49 (dd, J = 2.7, 1.5 Hz, 0.33H), 6.39 (dd, J= 5.1, 2.4 Hz, 
0.33H), 6.34 (dd, J = 2.4, 1.5 Hz, 0.66H), 6.29 (dd, J = 2.9, 0.5 Hz 0.33H), 6.27 (dd, J = 2.8, 
0.5 Hz, 0.33H), 4.35 (m, 0.66H), 4.13 (s, 0.33H), 3.38 (dd, J = 8.1, 0.7 Hz, 0.66H), 3.34 (dd, 
J = 7.8, 1.2 Hz, 0.33H), 3.07 – 2.85 (m, 2H), 2.74 – 2.63 (m, 2H), 2.39 (d, J = 3.9 Hz, 1H), 
2.32 – 2.26 (m, 1H), 2.22 – 2.02 (m, 2H), 1.99 – 1.85 (m, 2H), 1.02 (d, J= 7.3 Hz, 1H), 0.96 
(m, 2H). 
 
(±)-(4'S,5'S,6'S)-5'-methylspiro[[1,3]dithiane-2,8'-tricyclo[4.3.0.01,4]non[2]en]-9'-yl 
acetate (2.90) 
 
 Cyclobutene 2.78 (987 mg, 3.88 mmol, 1.0 equiv.), acetic anhydride (732 µL, 
7.76 mmol, 2.0 equiv.), 4-dimethylaminopyridine (47.5 mg, 0.388 mmol, 0.10 equiv.), 
and triethylamine (1.10 mL, 7.80 mmol, 2.0 equiv.) were combined with stirring in DCM 
(49.0 mL) in a 200 mL round bottom flask at room temperature under N2. The reaction 
was quenched with saturated aqueous sodium bicarbonate (10 mL) once TLC analysis 
(1:1 Et2O:hexanes) indicated complete consumption of starting material (3 hrs). The 
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layers were separated, the aqueous layer was extracted with DCM (3x15 mL) and the 
combined organic layers were dried over MgSO4, filtered, and concentrated. The 
resulting crude product was purified by silica gel chromatography (10:1 hexanes:Et2O) to 
afford 1.09 g (95%) of acetate 2.90 as a colorless oil consistent with known spectroscopic 
data.40 1H NMR (500 MHz, CDCl3) (2:1 diastereomeric mixture): δ 6.36-6.35 (m, 0.66H), 
6.27-6.25 (m, 0.66H), 6.19 (d, J= 2.4 Hz, 0.66H), 5.57 (s, 0.66H), 5.49 (s, 0.33H), 3.44 (d, 
J= 7.8 Hz, 0.33H), 3.21 (d, J= 8.1 Hz, 0.66H), 3.10-2.97(m, 2H), 2.70-2.52 (m, 2H), 
2.39-2.32 (m, 1H), 2.21-1.97 (m, 4H), 2.13 (d, J= 0.7 Hz, 2H), 2.12 (d, J= 0.7 Hz, 1H), 
1.91-1.80 (m, 1H), 0.98 (d, J= 7.1 Hz, 0.66H), 0.96 (d, J= 7.1 Hz, 0.33H). 
 
(±)-(4'S,5'S,6'S)-5'-methylspiro[[1,3]dioxolane-2,8'-tricyclo[4.3.0.01,4]non[2]en]-9'-yl 
acetate (2.91) 
 
 Cyclobutene 2.90 (46.8 mg, 0.158 mmol, 1.0 equiv.), ethylene glycol (630 µL), 
and acetonitrile (2.53 mL) were combined with stirring in a flame dried 20 mL vial under 
N2. Hg(ClO4)2 (158 mg, 0.395 mmol, 2.5 equiv.) was then added in one portion and the 
vial was quickly capped and submerged in a preheated 40 °C oil bath. After exactly 10 
minutes of stirring, the reaction was quickly quenched with saturated aqueous sodium 
bicarbonate (5 mL) and cooled to room temperature. The aqueous layer was extracted 
118
  
with Et2O (3x10 mL), and the combined organic layers were washed with brine (10 mL), 
dried over MgSO4, filtered and concentrated. The resulting yellow oil was purified by 
silica gel chromatography (10%, 15%, 20% Et2O in hexanes gradient) to afford 16.5 mg 
(42 %) of a mixture of two epimers of 2.91 as a colorless oil consistent with known 
spectroscopic data.40,43 1H NMR (500 MHz, CDCl3) (2:1 diastereomeric mixture): δ 6.28-
6.26 (m, 0.66H), 6.24 (dd, J=2.4, 1.5 Hz, 0.66H), 6.17 (d, J=2.4 Hz, 0.66H), 5.24 (s, 
0.66H),  4.74 (s, 0.33H), 4.9-3.85 (m, 4H), 3.34 (d, J =8.3 Hz, 0.66H), 3.18 (d, J =8.1 Hz, 
0.33H), 2.35-2.12 (m, 2H), 2.09 (s, 1H), 2.06 (s, 2H), 1.99-1.86 (m, 2H), 0.96 (m, 3H). 
 
(±)-(2'S,3'S,4'R,5'R,6'S,7'S)-ethyl 10'-acetoxy-6'-methylspiro[[1,3]dioxolane-2,9'-
tetracyclo[5.3.0.01,5.02,4]decane]-3'-carboxylate (2.115) 
 
 Starting acetate 2.91 (15.0 mg, 0.0599 mmol, 1.0 equiv.) and Cu(acac)2 (1.60 mg, 
0.00599 mmol, 0.10 equiv.) were dissolved in DCM (1.00 mL) in a flame dried 10 mL 
Schlenk flask with condenser and stir bar under N2. The blue-green reaction mixture was 
heated to 40 °C in an oil bath. Ethyl diazoacetate (63.0 µL, 0.599 mmol, 10 equiv.) was 
slowly added to the reaction mixture via syringe pump over 12 hrs. After TLC analysis 
(1:1 Et2O:hexanes) indicated completion of the reaction, the reaction was quenched with 
saturated aqueous ammonium chloride solution (1 mL) and extracted with DCM             
(3x2 mL) . The combined organic layers were washed with brine (2 mL), dried over 
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MgSO4, filtered and concentrated. The resulting yellow oil was purified by silica gel 
chromatography (20:1, 10:1, 2:1 hexanes: Et2O gradient) to afford 2.115 as a colorless oil 
with a small amount of an inseparable impurity consistent with known spectroscopic 
data.40,43 1H NMR (500 MHz, CDCl3): δ 4.95 (s, 0.66H), 4.50 (s, 0.33H), 4.16-3.81 (m, 
6H), 2.61 (dd, J =7.3, 2.7 Hz, 0.66H), 2.52-2.43 (m, 1H), 2.41 (dd, J = 7.3, 2.7 Hz, 
0.33H), 2.31-2.13 (m, 4H), 2.11 (s, 2H), 2.08 (s, 1H), 1.82-1.79 (m, 0.66H), 1.71 (d, J 
=0.7 Hz, 0.66H), 1.68 (s, 0.66H), 1.33-1.18 (m, 6H). 
 
(±)-(2'S,3'S,4'R,5'R,6'S,7'S)-3'-(2-hydroxypropan-2-yl)-6'-
methylspiro[[1,3]dioxolane-2,9'-tetracyclo[5.3.0.01,5.02,4]decan]-10'-ol (2.77) 
 
Methyllithium (1.60 M in diethyl ether, 374 µL, 0.599 mmol, 10 equiv.) was 
added dropwise to a stirring solution of cyclopropane ester 2.115 (20.1 mg, 0.0599 mmol, 
1.0 equiv.) and TMEDA (89.0 µL, 0.599 mmol, 10 equiv.) in THF (2.00 mL) at 0 ºC 
under N2. Stirring was continued at 0 ºC for 1 hr. The reaction mixture was then diluted 
with diethyl ether (1.5 mL) and quenched by slow addition of saturated aqueous 
ammonium chloride (3 mL). The aqueous layer was extracted with diethyl ether        
(3x10 mL) and the combined organic layer was dried over MgSO4, filtered and 
concentrated. The resulting product was purified by column chromatography on 
triethylamine washed silica gel (1:1, 5:1 EtOAc:hexanes gradient) to afford 7.90 mg 
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(47% over 2 steps) of diol 2.77 consistent with known spectroscopic data.40,43 α-2.77: 1H 
NMR (500 MHz, CDCl3): δ 4.09-4.04 (m, 1H), 3.98-3.92 (m, 3H), 3.72 (d, J = 9.5 Hz, 
1H), 2.50 (m, 1H), 2.43 (m, 1H), 2.05–1.95 (m, 2H), 1.72 (s, 1H), 1.69 (d, J = 6.1 Hz, 
2H), 1.61 (m, 1H), 1.49 (s, 1H), 1.22 (s, 6H), 1.17 (dd, J = 7.1, 1.5 Hz, 3H).13C-NMR 
(126 MHz, CDCl3): δ 116.39, 78.03, 70.08, 65.64, 65.28, 50.86, 41.64, 39.47, 38.34, 
35.42, 33.22, 29.33, 29.22, 23.70, 17.24, 15.19. IR (KBr thin film): 3387 (br), 2958 (s), 
2893 (m), 2869 (m), 1039 (m), 989 (m), 918 (m), 872 (m), 797 (s), 784 (s), 733 (s) cm-1. 
DART-HRMS (m/z): Calc’d for [M+H-H2O]+ (C16H24O4): 263.1647; Found: 263.1643.  
 
(±)-(2'S,3'S,4'R,5'R,6'S,7'S)-3'-(2-hydroxypropan-2-yl)-6'-
methylspiro[[1,3]dioxolane-2,9'-tetracyclo[5.3.0.01,5.02,4]decan]-10'-one (2.116) 
 
 Starting diol 2.77 (5.60 mg, 0.0200 mmol, 1.0 equiv) and 4 Å molecular sieves 
(10.0 mg) were dissolved in DCM (0.40 mL) in a small vial with stir bar under N2. The 
resulting solution was cooled to 0 °C and TPAP (7.00 mg, 0.0200 mmol, 1.0 equiv.) was 
added quickly to the vial. The reaction was allowed to stir at 0 °C for 40 minutes, at 
which point TLC analysis (4:1 EtOAc: hexanes) indicated full consumption of the 
starting material. The crude reaction mixture was quickly filtered through a short (2 cm) 
silica gel plug, eluting with Et2O, and the resulting filtrate was concentrated to afford a 
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yellow oil that was used immediately in the subsequent transformation. Crude reaction 
mixture containing product 2.116 and ~10% 2.76 and 2.117. 
 
(±)-(3aS,4R,7S)-7-(2-hydroxypropan-2-yl)-4-methyl-3,3a,4,7-tetrahydro-1H-
spiro[azulene-2,2'-[1,3]dioxolan]-1-one (2.76) & (±)-(3aR,4S,7S)-7-(2-
hydroxypropan-2-yl)-4-methyl-3,3a,4,7-tetrahydro-1H-spiro[azulene-2,2'-
[1,3]dioxolan]-1-one (2.117) 
 
 A flame dried vial equipped with stir bar was charged with RuCl3 (9.94 mg, 
0.0480 mmol, 2.4 equiv.) in an N2 filled glove box. The vial was removed from the glove 
box and placed under a positive flow of N2. The RuCl3 was dissolved in DCM (0.50 mL) 
and the resulting solution was cooled to -78 °C. Crude ketoacetal 2.116 (5.56 mg, 0.0200 
mmol, 1.0 equiv.) in DCM (0.50 mL) was transferred to the stirring solution by slow 
addition along the wall of the vial. The resulting reaction mixture was stirred at -78 °C 
for 1 hr. The reaction was then quenched with saturated aqueous sodium bicarbonate      
(1 mL), extracted with DCM (3x2 mL) and the combined organic layers were dried over 
MgSO4, filtered and concentrated. After 1H NMR analysis indicated only 77% 
conversion the crude material was re-subjected to the aforementioned reaction conditions 
for 0.5 hrs. Identical work up of the resulting reaction mixture produced the acid and base 
sensitive product in a 9:1 ratio of desired diastereomer 2.76: undesired diastereomer 
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2.117. This highly sensitive product mixture was immediately used in the subsequent 
transformation without further purification. 1H NMR (500 MHz, CDCl3) (only the major 
diastereomer is reported): δ 7.09-7.08 (m, 1H), 5.90 (ddd, J = 12.2, 7.6, 2.0 Hz, 1H), 5.59 
(dd, J = 12.0, 4.2 Hz, 1H), 4.40-4.36 (m, 1H), 4.16-4.06 (m, 3H), 3.36-3.26 (m, 2H), 
2.60-2.55 (m, 1H), 2.15 (dd, J = 14.2, 8.6 Hz, 1H), 1.91 (dd, J = 14.0, 9.3 Hz, 1H), 1.31-
1.28 (m, 6H), 0.98 (d, J = 7.1 Hz, 3H). 
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